Respiratory- other Flashcards

1
Q

Estimation of the basic reproduction number for Streptococcus equi spp. equi outbreaks by meta-analysis of strangles outbreak reports

A

• The conservative estimate of R₀ is 2.2 (95% CI: 1.9–2.5).
• Including outbreaks with a 100% attack rate (AR) yields a higher estimate of 2.7 (95% CI: 2.1–3.3).
• S. equi R₀ is lower than equine influenza (R₀ = 2–10), which can transmit via aerosols and over greater distances.
• The R₀ for outbreaks in individual housing was 2.0 (95% CI: 1.3–2.6), compared to higher estimates for group housing- reduced contact opportunities

• Herd immunity threshold for S. equi is approximately 62% (based on R₀ = 2.7).
• Achieving this threshold requires vaccines with >68% efficacy, which is feasible given current vaccine developments.

Outbreak-specific variations in R₀ are influenced by:
• Herd size and composition (juvenile vs. mixed-age).
• Housing conditions (group vs. individual stalls).
• Potential reduction in bacterial virulence during prolonged persistence in carriers.
• Smaller herds are more susceptible to stochastic effects, leading to greater variability in outbreak size.

Clinical and Epidemiological Implications
• The relatively low R₀ suggests that modest improvements in biosecurity could significantly reduce transmission risk.
• Examples include isolation of infected animals, improved hygiene, and screening of new arrivals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Potential for residual contamination by Streptococcus equi subspp equi of endoscopes and twitches used in diagnosis of carriers of strangles

A

• The study evaluates the efficacy of various disinfection methods for eliminating S. equi contamination from endoscopes and twitches.
• It addresses the risks of residual contamination and its potential to cause false-positive S. equi diagnoses or disease transmission.

3/4 disinfection methods effectively eliminated live S. equi bacteria:
• Automated Endoscope Reprocessor (AER) and manual cleaning with ortho-phthalaldehyde were the most effective.
• Ethanol-based disinfection (group A) failed in one sample, highlighting the risk of incomplete bacterial removal when using basic protocols.
Residual DNA Detection:
• No method completely eliminated S. equi DNA, as indicated by qPCR positivity in:
- 6/6 samples for ethanol-based cleaning.
- 1/6 samples for the AER method.
• Residual DNA could lead to false-positive qPCR results, complicating carrier identification.

Field Study Results:
• Endoscopes used on naturally infected horses were culture-negative after disinfection but one sample remained qPCR-positive, emphasizing the challenge of eradicating bacterial DNA under field conditions.

Disinfection of Twitches:
• All disinfection methods eliminated viable S. equi from plastic twitch handles.
• Sodium hypochlorite was the only disinfectant that completely removed S. equi DNA, making it a reliable option for minimizing cross-contamination during procedures.
Experimental vs. Field Conditions:
• Experimental contamination used high bacterial loads, likely higher than clinical scenarios.
• Field study methods were slightly less rigorous but achieved similar results, suggesting the experimental challenge represented a worst-case scenario.

• Disinfection protocols should combine manual cleaning and chemical disinfection to ensure removal of viable S. equi.
• Sodium hypochlorite is effective for DNA removal but poses environmental and safety concerns, requiring cautious use.
• Ortho-phthalaldehyde offers a viable alternative with broad-spectrum disinfection capability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Horses vaccinated with live attenuated intranasal strangles vaccine seroconvert to SEQ2190 and SeM

A

The study examines seroconversion in horses vaccinated with Pinnacle® IN, a live attenuated intranasal vaccine for Streptococcus equi (strangles), using the dual antigen iELISA targeting SEQ2190 (Antigen A) and SeM (Antigen C).
Discusses implications of vaccination on serology test interpretation and utility.

High Rate of Seroconversion:
• Vaccinated horses were 14 times more likely to return a seropositive or suspect iELISA result compared to non-vaccinated horses.
At 5 weeks post-vaccination (S2):
• 76% of vaccinated horses seroconverted to Antigen C.
• 48% seroconverted to both Antigen A and C.
• If using a lower cut-off value (OD450 ≥ 0.3), 100% of vaccinated horses were either seropositive or suspect.

Antigen-Specific Seroconversion Patterns:
• Antigen C seroconversion was expected due to its immunodominance in the SeM-2 strain used in the vaccine.
• Seroconversion to Antigen A, although less common, occurred in almost half of the vaccinated horses, suggesting some cross-reactivity.
Comparison with Non-Vaccinated Horses:
• Non-vaccinated horses had minimal seroconversion at S2 (4% for Antigen C).
• A small number of non-vaccinated horses were seropositive at S1 and S2, likely due to prior exposure, but guttural pouch sampling was not performed to confirm carrier status.

Influence of Age:
• Older horses (median age 15 years) were more likely to remain seropositive at 10 weeks (S3) compared to younger horses (median age 2 years).
• Younger horses often returned to seronegative status after the initial series, indicating potential age-related differences in humoral immunity.
Comparison with Other Vaccines:
• Results differ from cell-free extract and recombinant vaccines, which do not extensively interfere with the dual iELISA.
• Pinnacle® IN appears to cause more extensive seroconversion, particularly to Antigen C.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Failure of serological testing for antigens A and C of Streptococcus equi subspecies equi to identify guttural pouch carriers

A

• This study evaluates the reliability of serological testing (targeting antigens A and C) for detecting guttural pouch carriers of Streptococcus equi (S. equi), the causative agent of strangles.
• Highlights the significant limitations of serological tests in identifying chronic carriers of S. equi, emphasizing the need for microbiological sampling.
• There was no significant association between serological status and guttural pouch carriage of S. equi using either serological cut off.

• Of 287 included horses, 9 (3.1%) were found to be guttural pouch carriers.
• Only one of the nine carriers (11%) was seropositive using a cut-off of OD ≥ 0.5, and only three of nine (33%) using a cut-off of OD ≥ 0.3
• Of the 35 seropositive horses, one (2.9%) was found to have evidence of S. equi in a guttural pouch lavage and 34 (97.1%) did not.

Low Sensitivity of Serological Testing:
• The sensitivity of the antigen A/C ELISA was 11% at the higher threshold (OD ≥ 0.5) and 33% at the lower threshold (OD ≥ 0.3).
• Only 1 of 9 confirmed guttural pouch carriers was seropositive at the higher threshold, increasing to 3 carriers at the lower threshold.
• This low sensitivity indicates a high rate of false negatives, making serological testing unreliable for identifying carriers.
High Specificity and NPV:
• Specificity ranged from 77% (OD ≥ 0.3) to 88% (OD ≥ 0.5), meaning most non-carriers were correctly identified as seronegative.
• Negative predictive value (NPV) was 97%, reflecting the test’s reliability in ruling out carriers in populations with low prevalence.
Inconsistent Serological Responses in Carriers:
• Chronic guttural pouch carriage did not consistently stimulate a sustained antibody response.
• Seropositivity was not maintained in some cases of long-term carriage, suggesting immune tolerance, antigen shielding, or reduced bacterial antigenicity.

Potential Mechanisms for False Negatives:
• Antigenic shielding in chondroids or immune tolerance may reduce antigen availability for stimulating a sustained antibody response.
• Mutations or deletions in the S. equi genome might also explain the lack of antigenic stimulation in chronic carriers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Detection of Streptococcus equi subsp. equi in guttural pouch lavage samples using a loop-mediated isothermal nucleic acid amplification microfluidic device

A

This study evaluates the diagnostic performance of the eqbE loop-mediated isothermal nucleic acid amplification (LAMP) assay and its microfluidic device variant for detecting S. equi in guttural pouch lavage (GPL) samples.
Aims to compare these methods with the triplex real-time quantitative PCR (qPCR) as the gold standard.

Diagnostic Sensitivity and Specificity:
• The benchtop eqbE LAMP assay demonstrated 92% sensitivity and 71% specificity compared to qPCR.
• The eqbE LAMP microfluidic device achieved 100% sensitivity and 62% specificity.
• Both LAMP methods had comparable receiver operating characteristic (ROC) area under the curve (AUC ≈ 0.81), indicating similar diagnostic performance.

Advantages:
• The LAMP microfluidic device had a lower LOD (1 colony-forming unit, CFU) than qPCR (10 CFU for SEQ2190 and 20 CFU for eqbE),
• The LAMP microfluidic device delivered results within 15–40 minutes
• The eqbE target in the triplex qPCR assay was inhibited in some cases, possibly due to primer competition, leading to variable sensitivity depending on the sample’s bacterial load.
Environmental Contamination Risks:
• The risk of contamination causing false positives was deemed minimal due to the closed system design of the LAMP microfluidic device.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Repeated nasopharyngeal lavage predicts freedom from silent carriage of Streptococcus equi after a strangles outbreak

A

The study evaluates the effectiveness of repeated nasopharyngeal lavage (NPL) sampling in identifying horses free of Streptococcus equi (S. equi) carriage after a strangles outbreak.
Focuses on the diagnostic utility of NPL compared to guttural pouch lavage (GPL) and the potential for NPL to predict carrier-free status in herd management.

Utility of Repeated NPL:
• Horses with at least three NPL samples testing negative for S. equi across four sampling occasions (weeks 18–30) were significantly more likely to be carrier-free at week 45.
• Ten of eleven horses with three negative NPL samples were S. equi-free at week 45, indicating strong predictive potential (P = 0.03).
Limitations of Single GPL Sampling:
• Sole reliance on GPL at week 45 would have missed 29% (4/14) of the carriers identified, as they were only positive on NPL.

• False negatives still occur: 1/24 carriers tested negative in three prior NPL samples but was positive at week 45.
• The study suggests that combining GP and NP lavage to minimise false negatives and improving overall sensitivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Efficacy of high-level disinfection of endoscopes contaminated with Streptococcus equi subspecies equi with 2 different disinfectants

A

• This study evaluates the effectiveness of accelerated hydrogen peroxide (AHP) and ortho-phthalaldehyde (OPA) in high-level disinfection of endoscopes contaminated with Streptococcus equi subsp. equi (S. equi).
• Aims to assess their ability to eliminate viable bacteria and residual DNA to prevent false-positive qPCR results.

• Both AHP and OPA successfully eliminated all viable S. equi bacteria, as confirmed by culture results (100% culture-negative across all tests).
• Despite effective bacterial elimination, residual S. equi DNA was frequently detected by qPCR:
-AHP: 33% qPCR-positive samples.
-OPA: 73% qPCR-positive samples.
-Control (water): 71% qPCR-positive samples.
• AHP demonstrated a significantly lower probability of qPCR positivity compared to OPA and control.
• Considerable variability in qPCR results was observed between testing days, with the highest rate of qPCR-positive samples on Day 5 (>90%).
-Likely contributors include environmental contamination, human error, or inconsistencies in disinfection procedures.

Mechanisms of Action:
• AHP: Works via oxidative damage to nucleic acids, proteins, and lipids. Its lower residual DNA detection suggests superior effectiveness in degrading bacterial DNA compared to OPA.
• OPA: Functions by cross-linking amino acids and increasing membrane permeability but is less effective in DNA degradation under the tested conditions.

• Currently, the disinfectants most currently used are OPA products, which require 12 minutes of contact time with the endoscope.
• Commercial hydrogen peroxide is another broad-spectrum antimicrobial, but most products containing hydrogen peroxide are highly corrosive to endoscopes.
• Accelerated hydrogen peroxide (AHP) is a newly developed product that is a blend of 2% hydrogen peroxide, surfactants, and stabilizers. This AHP product is compatible with flexible endoscopes, and only requires an 8-minute contact time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Influence of penicillin treatment of horses with strangles on seropositivity to Streptococcus equi ssp. equi-specific antibodies

A

This study investigates the impact of penicillin treatment during acute clinical strangles on the development and persistence of humoral immunity against S. equi antigens.
Highlights significant differences in serological responses among horses treated early, late, or not treated with penicillin during the outbreak.
• Reasons for penicillin treatment in the acute phase included decreased appetite, high or persistent fever, and lethargy, combined with owner pressure regarding horses with prolonged or worsening clinical abnormalities

Reduced Humoral Immunity in Early Treated Horses:
• Horses treated with penicillin within 11 days of fever onset (Group 1) exhibited a significantly faster decline in antibody titers against antigens A and C compared to other groups.
• By 4 months post-infection (T123), only 57% of Group 1 remained seropositive for either antigen, compared to 100% in Group 2 and 93% in Group 3.
Delayed Treatment and Untreated Groups:
• Horses treated after 16 days of fever onset (Group 2) maintained antibody titers comparable to untreated horses (Group 3). This suggests delayed antibiotic administration may allow sufficient immune activation to sustain long-term antibody production.
Seropositivity and Carrier State:
• The proportion of long-term silent carriers (identified by qPCR and culture) did not significantly differ between groups.
• Reinfection through nose-to-nose contact in shared paddocks was likely responsible for seropositivity in some horses during the final sampling.

• clinical scores were not significantly different (P = .12-1.0), but those treated after 16 days of fever had numerically higher clinical scores (Table 2) at sampling T27

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Markers of long-term silent carriers of Streptococcus equi ssp. equi in horses

A

• The study evaluates the ability of clinical markers, inflammatory parameters, and serological assays to identify long-term silent carriers of Streptococcus equi (S. equi) after outbreaks of strangles.
• Highlights challenges in identifying silent carriers due to the absence of consistent clinical signs or systemic inflammation.

• Apart from weanlings at 6 months in outbreak A, there was no significant association between any clinical markers or serology with carrier state (P = .06-1).
• Moreover, 3/12 culture positive carriers were seronegative to S. equi.
• only endoscopic score significantly associated with carriers. Non-carriers had significantly higher clinical scores.

• The sensitivity and specificity values for serology to either antigen A or C in detection of carrier varied between outbreaks and animal groups, with sensitivity ranging from 0 to 86%, specificity 47 to 100%. In turn, likelihood ratios often approached 1, but varied between 0 and infinity

Weanlings 6 months after outbreak:
• endoscopy score was significantly higher in the carriers (chi square 11.3, P = .003).
• Seropositivity to S. equi at 6 months was significantly associated with carriers
• no significant differences by 14 months

• Guttural pouch abnormalities (e.g., empyema or chondroids) were observed in some carriers, but not all.
• A significant overlap in endoscopic scores between carriers and non-carriers suggests that guttural pouch examination alone cannot reliably identify carriers.

Carrier State and Bacterial Persistence:
• Carriers identified by qPCR but not culture likely harbor viable but non-culturable S. equi, which may still pose a transmission risk.
• Some culture-positive carriers tested seronegative, indicating that seropositivity does not necessarily persist in long-term carriers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A long-term study of sinoscopic treatment of equine paranasal sinus disease: 155 cases (2012–2019)

A

The study assesses the effectiveness and limitations of sinoscopic treatment for equine paranasal sinus disorders.
Focused on long-term outcomes, intraoperative challenges, reasons for treatment failure, and postoperative complications.
Emphasizes the minimally invasive nature of sinoscopy compared to traditional sinusotomy.

Key Findings
• 96.1% (149/155) of horses showed full long-term improvement after initial or subsequent treatments.
• Sinoscopy proved effective in treating most cases of sinus disease with fewer complications compared to sinusotomy.

Failure to access the rostral maxillary sinus (RMS) and ventral conchal sinus (VCS) was attributed to:
• Osteitis-related thickening and sclerosis of the maxillary septal bulla (MSB).
• Anatomical variations, such as an enlarged infraorbital canal near the nasal concha.
• Recommendations include using narrower endoscopes or alternative portals for improved access in complex cases.

The main reasons for non-responsiveness in 30.3% of cases (47/155) included:
• Intra-sinus sequestrae (19.1% of complications).
• Inspissated exudate in sinuses (12.8%).
• Concurrent nasal disorders, including sequestrae, inspissated exudate, or fungal plaques (14.9%).
• Misdiagnosed dental sinusitis, sinonasal drainage obstruction, or progressive ethmoid hematomas (PEH).

Concurrent Nasal Lesions:
• High prevalence (38%–67%) of middle meatus lesions, such as infected nasal conchal bullae, in cases of sinusitis.
• Highlights the need for careful nasal endoscopy to detect concurrent issues affecting treatment outcomes.

• Only 2.6% (4/155) of cases required surgical fenestration to address drainage obstructions, emphasizing the efficacy of sinoscopic techniques combined with lavage and anti-inflammatory treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Genipin treatment of equine palatal dysfunction: A preliminary study of safety and efficacy

A

Unblinded, uncontrolled and with subjective outcome= case series
This study evaluates the safety and feasibility of using genipin, a collagen cross-linker, for treating palatal dysfunction (PD) in racehorses.
Demonstrates that genipin implantation is a quick, minimally invasive procedure with minimal time off exercise, offering a potential first-line surgical option for cases unresponsive to conservative management.

The procedure was well-tolerated, with minimal adverse reactions:
• One horse had delayed return to exercise due to pyrexia and moderate palatal edema, resolving with treatment.
• Mild palatal reactions (e.g., focal swelling, edema, or superficial ulcers) occurred in six horses but resolved without major intervention.
• No complications were reported in the seven horses undergoing repeat implantation.

Efficacy in Reducing Palatal Dysfunction:
• Trainer-reported improvement in 76% of horses, comparable to other surgical interventions for PD.
• 42% of horses showed clinical resolution of PD signs and improved racing performance, while others exhibited subjective improvements in respiratory function or training response.

Improved Outcomes with Modified Implantation Technique:
• Adverse reactions were more common in the first cohort, where larger volumes of genipin (1 ml/site) were used.
• Modifications (0.5 ml/site in six implantation locations) resulted in better distribution and reduced adverse effects, suggesting operator experience and technique optimization play a crucial role.

Comparison with Other Treatments:
• Genipin implantation showed similar or superior outcomes compared to traditional procedures like laryngeal tie-forward or laser palatoplasty.
• Advantages include minimal invasiveness, rapid recovery, and no need for major surgery or foreign material placement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Conventional imaging is useful for assessment of equine pharyngeal squamous cell carcinoma but underestimates bone involvement

A

The case series evaluates the utility of radiography, ultrasonography (US), and computed tomography (CT) in diagnosing pharyngeal squamous cell carcinoma (SCC) in horses.
Focuses on the effectiveness of these imaging modalities in identifying tumor extent, lymphadenopathy, and bone involvement.

Utility of Conventional Imaging:
• Radiography and ultrasonography -Both methods allow for identification of retropharyngeal and mandibular lymphadenopathy, aiding in the detection of possible metastases.
Limitations of Radiography:
• Radiography consistently underestimated the extent of bone lysis compared to CT, primarily due to tissue superimposition.
• Bone lysis associated with SCC was identified only via CT, underscoring the limitations of radiographs in assessing osseous involvement.
Advantages of CT:
• CT provided detailed visualization of aggressive bone lysis, new bone formation, and tumor spread to adjacent structures.
• It revealed bone metastases in two cases, which were undetected on radiographs
Role of Ultrasonography:
• US was effective in visualizing soft tissue masses, lymphadenopathy, and guided fine-needle aspiration biopsies.
• While bone lysis was less apparent on US compared to CT, it successfully confirmed metastatic lymphadenopathy in 5/6 cases.
Challenges in Endoscopic Examination:
• Endoscopy was inconclusive in some cases due to nasal passage obstruction or displacement of the soft palate, highlighting the importance of alternative imaging methods.
Metastatic Patterns:
• SCC metastasis to retropharyngeal lymph nodes was common, with bone metastases identified in the hyoid apparatus in one horse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Equine sinusitis aetiology is linked to sinus microbiome by amplicon sequencing

A

This study explored the microbiota of equine sinusitis through next-generation sequencing (NGS), identifying distinct microbial profiles linked to primary sinusitis (PS), dental-related sinusitis (DRS), and other secondary causes (OS).
Demonstrates the advantages of molecular sequencing over traditional culture methods in understanding sinus microbiomes and guiding treatment.Distinct Microbial Profiles by Aetiology:

• DRS: Associated with higher microbial diversity, bioburden, and obligate anaerobes, including Fusobacterium, Odoribacter, Bacteroides, and Mycoplasma.
-Often linked to periodontal disease.
• PS: Characterized by low microbial diversity and dominance of a single species, most commonly Streptococcus equi.
• OS: Exhibited high genetic variation and lower bioburden, reflecting diverse causes (e.g., cysts, tumors).

Fungal Components:
• Fungi were detected in only 6% of cases, exclusively within DRS.
• Common fungal genera included Scedosporium, Fusarium, and Aspergillus, often in horses with prior antimicrobial use.
• Results suggest a greater fungal component in DRS compared to other types of sinusitis- consider antifungals?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Radiographic tracheal lumen to vertebral ratios in the normal American Miniature Horse

A

This study provides baseline reference data for tracheal lumen to vertebral body ratios in clinically normal American Miniature Horses.
Explores the prevalence of subclinical tracheal collapse (STC) in this population, highlighting its importance for early diagnosis and management.

Radiographic Measurements and Ratios:
• The tracheal lumen to vertebral body height (TL-VBH) and tracheal lumen to vertebral body length (TL-VBL) ratios were established as baseline references for normal American Miniature Horses.
Prevalence of Subclinical Tracheal Collapse (STC):
• 14.7% (5/34) of the horses exhibited STC, a higher prevalence than previously reported (6%).
• STC was characterized by 25–50% tracheal narrowing (grades 1–2) and did not progress to severe narrowing (grades 3–4).
Age-Related Predisposition:
• Subclinical cases were older, with an average age of 20 years compared to 7 years in the normal group, suggesting that geriatric horses are at higher risk of developing tracheal narrowing.
Dynamic and Morphological Findings:
• Radiography and fluoroscopy identified consistent patterns of tracheal narrowing, particularly at the thoracic inlet, similar to trends observed in other equine breeds and species.
• Normal respiratory fluctuations in tracheal diameter did not exceed 28%, indicating the static nature of tracheal narrowing in subclinical cases.
Histopathological Insights:
• Rare to mild loss of chondrocytes was noted histologically, without cartilage degradation or fragmentation, distinguishing subclinical cases from severe tracheal collapse seen in other species.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Computed tomography characteristics of equine paranasal sinus cysts

A

This study investigates the computed tomography (CT) features of paranasal sinus cysts in horses and their differentiation from other sinus diseases.
Findings focus on the unique imaging characteristics of sinus cysts and their implications for diagnosis and treatment planning.

Cyst Wall Characteristics:
• The presence of a hyperattenuating cystic wall was observed in 7 of 8 horses with sinus cysts.
• Mineralization of the cyst wall ranged from diffuse to focal and linear patterns, providing a distinct marker for diagnosis.
• Histopathology revealed the cyst walls contained a combination of ossification, hemorrhage, and fibrosis, contributing to their CT appearance.
Contrast Enhancement:
• Variable contrast enhancement of the cystic wall was observed in 3 of 7 cases that received intravenous contrast.
• This variability may be due to differences in the timing of imaging post-contrast administration or structural heterogeneity of the cyst walls.
Contents of the Cyst:
• The contents of the cyst were predominantly fluid or soft tissue with no significant difference in attenuation values compared to other sinus diseases.
• Presence of internal gas was observed in two cases, attributed to either previous surgical trephination or unknown causes.
Bone Changes:
• Cortical bone loss and cancellous bone destruction were frequent findings in both the sinus cyst group and other sinus disease groups, suggesting active bone remodeling.
• Histopathology demonstrated osteoclastic activity and inflammation, contributing to bone loss and remodelling in cystic cases.
Comparison with Other Sinus Diseases:
• Some features, such as hyperattenuating margins, were also found in other diseases like ethmoid hematomas and neoplasia, but internal mineralization patterns helped differentiate these conditions.
• Chronic primary sinusitis lacked definitive features for differentiation from sinus cysts in some cases.
Dental Associations:
• Cases of sinus cysts with dental abnormalities, such as compound odontomas and periapical infections, were identified, indicating potential odontogenic origins in some cysts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Evaluation of the effect of laser salpingopharyngostomy on the guttural pouch environment in horses

A

This study evaluates how laser salpingopharyngostomy (LSP) alters the guttural pouch environment in healthy horses.
Highlights potential implications for using LSP as an adjunct treatment for guttural pouch diseases, including tympany, chondroids, chronic empyema, and mycosis.

• The guttural pouch environment was altered by the laser salpingopharyngostomy.
• Baseline recorded values within the guttural pouch were highly constant within each horse but varied between horses ? disease susceptibility.
• Post laser salpingopharyngostomy there was considerable variation within the guttural pouch between horse and during the period of sampling.
• CO2 levels post laser salpingopharyngostomy were significantly more variable than free- appeared to be linked directly to the horse’s respiratory pattern with peaks and troughs recorded
• There was a statistically significant (P < .05) increase in variance in O2 levels during sampling after the laser salpingopharyngostomy in 4 out of 6 individual horses when comparing day 0 to day 7. Comparisons of day 7 variance to day 14 variance for O2 indicated that there was a significant decline at day 14 for one horse (P < .001).
• There was no change in humidity or temperature during the study

• at 3 months, 5/6 had completely healed. The one non-healing remained similar at 12 months
• The GPs themselves were unremarkable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Immunohistochemical analysis of laryngeal muscle of horses clinically affected with recurrent laryngeal neuropathy

A

The study investigates the changes in muscle fiber type, size, and regenerative markers in the left cricoarytenoideus dorsalis (L-CAD) muscle of Thoroughbred horses clinically affected by recurrent laryngeal neuropathy (RLN).
Focuses on the pathological and compensatory processes occurring in the L-CAD muscle and their implications for RLN progression and treatment.

Key Findings
• Clinically affected horses showed significant atrophy in overall muscle fiber diameter, particularly in type IIA and IIX fibers.
• Expression of embryonic myosin heavy chain (MyHC) in affected horses indicates active regeneration and fiber renewal, suggesting that denervation stimulates regenerative processes.
Fiber-Type Grouping:
• Affected horses exhibited prominent fiber-type grouping, indicative of partial denervation followed by reinnervation.
• Fiber-type grouping reflects chronic or intermittent nerve damage, with surviving nerve terminals innervating adjacent denervated fibers.
Shift in Fiber Composition:
• Loss of IIX fibers, the fastest fibers in equine L-CAD, was observed in affected horses, replaced by embryonic fibers.
• While loss of IIX fibers is tolerated in subclinical cases, the reduction in fatigue-resistant type I fibers and type IIA fibers in clinically affected horses likely contributes to the inability to maintain arytenoid abduction during exercise.
Compensatory Hypertrophy:
• Some remaining muscle fibers showed hypertrophy, suggesting an adaptive response to maintain partial function. However, this was insufficient to counteract the overall loss of muscle bulk.
Potential for Regenerative Therapy:
• The presence of embryonic myosin suggests that reinnervation strategies, such as nerve grafts or stimulation therapies, may be viable before fibrosis becomes extensive.

Clinical Implications
• Pathogenesis of RLN: The loss of type IIX fibers and reduction in fatigue-resistant fibers are key pathological changes distinguishing clinically affected horses from subclinical cases.
• Functional impairment in RLN is likely due to the combined effects of fiber atrophy, loss of fast fibers, and reduced endurance capacity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Upper airway endoscopy in exercising horses: Findings in 164 barrel racing horses with respiratory clinical signs and/or poor performance

A

High Prevalence of UAOs:
• Approximately 88% of the evaluated barrel racers had one or more UAOs during exercise.
• The most common UAOs were:
-Palatal instability (PI) and intermittent dorsal displacement of the soft palate (iDDSP): 62%.
-Nasopharyngeal collapse (NPC): 41%.
-Arytenoid abnormalities, including recurrent laryngeal neuropathy (RLN): 30%.
-Vocal fold collapse (VFC): 24%.

• 56% presented with two or more concurrent UAOs, indicating multifactorial airway dysfunction.
• Co-occurrences were observed between laryngeal and pharyngeal obstructions, suggesting interdependence between anatomical regions.

Exercise Intensity and UAO Timing:
• UAOs were more prevalent during low-speed/low-intensity exercise (55%) compared to high-speed/high-intensity phases (22%).
• iDDSP was notably more frequent at lower intensities, possibly due to anticipatory stress, muscle tension, or head-neck positioning.

Unique Observations in Barrel Racers:
• Barrel racing horses displayed distinct patterns of UAO compared to other equine sports.
• Active glottic closure during high-speed barrel turns was identified, suggesting adaptive mechanisms for thoracic stabilization during explosive movements.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

External transcutaneous ultrasound technique in the equine cricoarytenoideus dorsalis muscle: Assessment of muscle size and echogenicity with resting endoscopy

A

This study validates the use of transcutaneous ultrasonography for assessing the cricoarytenoideus dorsalis (CAD) muscle as a diagnostic tool for recurrent laryngeal neuropathy (RLN) in horses.
Demonstrates that transcutaneous ultrasound is a reliable, non-invasive method that correlates well with resting endoscopic grades and physical measurements.

Key Findings
• Thickness and cross-sectional area of the left CAD (LCAD) were significantly reduced in horses with grades 3 and 4 RLN.
• Increased echogenicity of LCAD was observed in RLN-affected horses, indicating muscle atrophy.
• LCAD:RCAD Ratios:
-Ratios of thickness and cross-sectional area were significantly lower in horses with advanced RLN (grades 3.II, 3.III, and 4) compared to controls.
-Findings suggest that compensatory hypertrophy of the right CAD (RCAD) occurs to maintain partial laryngeal function in RLN.
•There was a strong correlation (R = 0.6) between physical measurements taken during laryngoplasty and ultrasound assessments, supporting the accuracy of the ultrasound technique.
• Increased echogenicity, quantified by grey-scale analysis, corresponded to RLN severity.

Advantages Over Transoesophageal Ultrasonography (TEU):
• Transcutaneous ultrasonography is less invasive, more accessible, and quicker than TEU, making it a practical choice for field diagnostics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Nasopharyngeal bacterial and fungal microbiota in normal horses and horses with nasopharyngeal cicatrix syndrome

A

The study explores the differences in the nasopharyngeal bacterial and fungal microbiota between healthy horses and those affected by nasopharyngeal cicatrix syndrome (NCS).
Emphasizes the role of environmental and microbial factors in the etiology of NCS, with specific interest in fungal genera like Bipolaris.

Microbiota Composition in Healthy Horses:
• The nasopharyngeal microbiota of healthy horses was dominated by Staphylococcus, Streptococcus, Moraxella, and Corynebacteria.
• Fungal components included Aspergillus, Wallemia, Rhodotorula, Saitozyma, and Cladosporium.
Microbial Differences in NCS-Affected Horses:
• Bacterial microbiota differences:
-Decrease in Staphylococcus abundance in NCS-affected horses, likely a consequence of underlying disease processes.
-No significant overgrowth of other bacterial genera in affected horses, suggesting a limited role for bacterial dysbiosis.
• Fungal microbiota differences:
-Increased abundance of Bipolaris and Microascus in NCS-affected horses. Bipolaris is of particular interest due to its known pathogenicity in the nasal sinuses and potential as a causative agent in NCS.

Environmental Associations:
• Farms housing NCS-affected horses had significantly higher fungal genera like Bipolaris and Alternaria compared to unaffected farms.
• These findings highlight the potential role of environmental exposure in NCS development.

Role of Pythium insidiosum:
• Contrary to anecdotal beliefs, Pythium insidiosum was not detected in any horses, ruling it out as a likely etiological agent of NCS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Race performance following epiglottic entrapment surgery in Thoroughbred yearlings

A

• The study evaluates the long-term race performance of Thoroughbred (TB) yearlings surgically treated for epiglottic entrapment.
• Assesses whether surgical treatment impacts racing performance compared to untreated maternal half-siblings and identifies factors influencing the likelihood of racing post-surgery.

No Significant Impact on Performance:
• Surgically treated yearlings exhibited similar racing performance metrics (career longevity, total races, earnings) compared to untreated maternal half-siblings.
• Supports the hypothesis that surgical correction of epiglottic entrapment does not adversely affect racing outcomes when other upper airway abnormalities are absent.
Influence of Concurrent Abnormalities:
• Horses with concurrent abnormal right arytenoid movement were significantly less likely to race post-surgery (OR 15.40).
Gender Representation:
• Females were overrepresented in the treated cohort (71.2%), consistent with some prior studies in mature horses but not others.
Sub-Epiglottic Cysts and Ulceration:
• Sub-epiglottic cysts were identified in 13.1% of yearlings and may predispose horses to epiglottic entrapment.
• Ulceration of entrapping tissue was less common in yearlings (54.1%) than in adult TBs, likely due to reduced dynamic airway stress in younger horses.
Epiglottic Hypoplasia:
• Found in 42.9% of treated yearlings but was not a significant predictor of racing performance post-treatment in multivariable models.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Culture-independent and dependent evaluation of the equine paranasal sinus microbiota in health and disease

A

The study characterizes the microbiota of the equine paranasal sinuses in healthy horses and horses with sinusitis using both culture-dependent and culture-independent methods.
Explores the bacterial and fungal organisms present and their potential roles in health and disease.

• The sinus microbiota in healthy horses primarily consists of aerobic bacteria and fungi.
• Culture-independent analysis revealed significantly greater microbial diversity compared to culture-dependent methods.
• Key bacterial phyla identified included Proteobacteria, Firmicutes, and Actinobacteria, while fungi such as Aspergillus and Malassezia were prominent.

Differences Between Health and Disease:
• Healthy sinuses lack substantial anaerobic bacterial populations, contrasting with sinusitis cases dominated by anaerobic species.
• Horses with sinusitis often displayed polymicrobial infections, with common pathogens including Streptococcus equi subsp. zooepidemicus and Fusobacterium spp.
• These findings suggest that the presence of anaerobes may indicate a shift from a commensal to a pathogenic microbiota.

Empirical Antimicrobial Therapy:
• Many horses with sinusitis receive antibiotics without prior culture and sensitivity testing, which may be less effective against polymicrobial and anaerobic infections.
• Reported antimicrobial susceptibility patterns indicate high sensitivity of anaerobic bacteria to chloramphenicol, metronidazole, and penicillin.
Unique Microbial Profiles:
• Individual horses demonstrated unique sinus microbiota compositions, likely influenced by factors such as environment, diet, and housing.
• Principal coordinate analysis highlighted the variability in microbial populations across horses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Efficient primary surgical treatment of equine infectious sinusitis reduces postoperative aftercare and increases outcome results: a retrospective study of 130 cases

A

This study evaluates the outcomes of surgical treatments for primary and dental-related equine sinusitis.
Compares sinoscopic (minimally invasive) and sinusotomy (invasive) approaches while highlighting the importance of diagnostics, postoperative care, and long-term management.

High Success Rates:
• Single surgical treatment resolved clinical signs in 82.3% of cases.
• After second or third treatments, 98.5% of horses achieved long-term resolution of sinusitis symptoms.
Surgical Approaches:
• Sinoscopy was the preferred method due to lower complication rates and shorter recovery times compared to sinusotomy.
• Horses undergoing sinusotomy often had more severe or complex pathologies, necessitating a more invasive approach.

The study emphasizes a simplified postoperative care protocol:
• Daily flushing with sterile saline via a needle rather than leaving a Foley catheter in place, which reduced infection risks and stress.
• Minimal reexamination requirements compared to previous techniques, improving efficiency.

Role of Advanced Imaging:
• Computed tomography (CT) improved diagnostic accuracy and guided treatment decisions, particularly in cases where radiographs were inconclusive.
• CT imaging identified subtle pathologies such as sinonasal stenosis, dystrophic mineralization, and complex dental lesions.

Dental Pathology as a Major Cause:
• Dental issues accounted for 66.2% of cases, with apical infections, fractures, and periodontal disease being the most common etiologies.
• Advances in dental diagnostics and minimally invasive techniques have improved the management of secondary dental sinusitis.

Complications and Management:
• Short-term complications (e.g., surgical site infection, periostitis) were rare, occurring in 6.2% of cases.
• Effective hemostasis methods and the avoidance of unnecessary equipment (e.g., Foley catheters) minimized postoperative infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Training the equine respiratory muscles: Inspiratory muscle strength

A

This study investigates the effects of conventional exercise training and high-load inspiratory muscle training (IMT) on inspiratory muscle strength (IMSi) in racehorses.
Demonstrates significant improvements in IMSi with high-load IMT, offering insights into optimizing respiratory function and performance in equine athletes.

Effect of Conventional Training:
• Significant increases in IMSi were observed following 12 weeks of conventional exercise training, aligning with similar findings in human athletes.
• This suggests that regular training improves respiratory muscle function, particularly in horses conditioned for race fitness.
Impact of High-Load IMT:
• High-load IMT resulted in a further significant increase in IMSi, work, power, and inspiratory volume compared to conventional training alone.
• The improvements were not replicated in the low-load control group, confirming the specific training effect of high-load IMT on respiratory muscles.
Low-Load IMT as a Control:
• The low-load IMT group served as a sham control and showed no significant changes in IMSi or associated parameters, validating the efficacy of the high-load protocol.

Safety and Behavioural Observations:
• The application of IMT was well-tolerated by the majority of horses, with only two horses exhibiting avoidance behaviors severe enough to prevent training.
• Behavioral responses were infrequent during IMT sessions, indicating good overall compliance and feasibility for routine application.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Training the equine respiratory muscles: Ultrasonographic measurement of muscle size

A

This study investigates changes in respiratory and locomotor muscle sizes in Thoroughbred racehorses undergoing conventional race training and inspiratory muscle training (IMT).
Utilizes ultrasonography to measure muscle size changes and explores their implications for athletic performance and respiratory function.

Conventional Training Effects:
• Significant increases in the diaphragm size were observed after 12 weeks of conventional training
• Continued race fitness training led to reductions in diaphragm thickness, possibly due to a shift from strength-based adaptations to endurance adaptations.
Impact of High-Load IMT:
• High-load IMT either maintained or increased diaphragm thickness compared to low-load IMT or no IMT, aligning with findings in human athletes.
• This suggests hypertrophy in diaphragm fibers, potentially enhancing respiratory muscle strength and endurance.
Asymmetry in Diaphragm Measurements:
• The left diaphragm was consistently thicker than the right across all time points, which may result from anatomical or functional differences (e.g., adjacent organ pressure or locomotor-induced thoracic asymmetry).

Upper Airway Muscle Responses:
• Upper airway muscles (e.g., thyrohyoideus and cricothyroideus) increased in size during continued race fitness training, suggesting hypertrophy in response to strenuous exercise.
• IMT did not significantly alter upper airway muscle size, indicating that whole-body exercise may be more effective for developing these muscles.

Accessory and Locomotor Muscles:
• Changes in accessory respiratory muscles were variable and may reflect their secondary roles in respiration and mastication.
• Conventional training reduced asymmetry in locomotor muscles (e.g., gluteus medius), promoting balanced development.
Airway Surgery Influence:
• Horses without previous airway surgery exhibited greater gluteal muscle growth, suggesting possible links between upper airway function and locomotor muscle conditioning.

Athletic Performance Correlations:
• Preliminary analyses indicated a potential association between diaphragm thickness and race performance, though this did not reach significance in multivariable analyses.
• This finding warrants further exploration in larger populations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Inspiratory muscle training for the treatment of dynamic upper airway collapse in racehorses: A preliminary investigation

A

This preliminary study explores the feasibility and potential benefits of inspiratory muscle training (IMT) in managing dynamic upper airway collapse (UAC) in racehorses.
UAC is a significant issue in equine sports, leading to poor performance and welfare concerns.
IMT aims to strengthen upper airway muscles to improve airway stability during exercise.

• IMT was well-tolerated by all horses included in the study, with no adverse effects reported.
• The protocol was successfully implemented in client-owned horses, demonstrating its practicality in a real-world setting.
Improvement in Upper Airway Function:
• Post-IMT assessments showed a reduction in the severity of dynamic airway obstructions in many cases:
• Decrease in vocal fold collapse (VFC) grades in 6 out of 9 horses.
• Palatal instability (PI) and intermittent dorsal displacement of the soft palate (iDDSP) grades improved in 7 out of 10 and 5 out of 7 horses, respectively.
• Medial deviation of the aryepiglottic folds (MDAF) grades decreased in 7 out of 9 horses.
• However, improvements were not universal, and some horses showed minimal or no changes.

Potential Mechanisms of Action:
• IMT likely activates and strengthens upper airway and respiratory muscles, contributing to improved airway stability.
• This aligns with human studies where IMT has shown benefits for vocal cord dysfunction and palatal abnormalities.

Role of Conventional Training:
• Conventional race training alone may improve upper airway muscle function, complicating the assessment of IMT’s independent effects.
• Some improvement in airway function could be attributed to ongoing exercise training.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

A bitless bridle does not limit or prevent dynamic laryngeal collapse

A

The study evaluates whether Dr. Cook’s™ Bitless Bridle reduces the severity of dynamic laryngeal collapse (DLC) compared to a conventional snaffle bit bridle in Norwegian Swedish Coldblooded Trotters.
DLC is a common form of upper respiratory tract obstruction associated with poll flexion during exercise, negatively impacting performance.

• No significant differences in the severity of DLC were observed between the bitless and snaffle bit bridles during poll flexion.
• Changes in head and neck position, driven by rein tension, were identified as key factors in inducing DLC in susceptible horses.
• Poll flexion alters the relative positions of the larynx and hyoid apparatus, contributing to airway collapse.

• Inspiratory pressures during free head carriage were more negative with the snaffle bit bridle compared to the bitless bridle.
• During poll flexion, when DLC occurred, inspiratory pressures were similar between the two bridles, reinforcing the finding that the bit does not significantly affect DLC pathogenesis.
• Hypotheses suggesting that snaffle bits influence airway mechanics via their effects on the tongue and hyoid apparatus were not supported.
• Neither nasopharyngeal collapse nor dorsal displacement of the soft palate was observed in any horses, regardless of bridle type or rein tension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Outcome analysis of 95 harness racehorses with confirmed dorsal displacement of the soft palate treated with laryngeal tie-forward surgery

A

This study evaluates the outcomes of harness racehorses undergoing laryngeal tie-forward (LTF) surgery for intermittent dorsal displacement of the soft palate (iDDSP).
Analyzes postoperative performance metrics, recurrence rates, and potential complications.

Key Findings
• Horses demonstrated significant declines in performance indices (PI) and racing speed before surgery.
• Postoperatively, 66.7% of horses improved their PI, and 65.7% showed faster racing speeds, supporting the efficacy of LTF in restoring athletic performance.
• iDDSP recurred in 21% of horses within 2 years, indicating a need for follow-up care and potentially additional interventions.
• Short-term complications occurred in 10.5% of cases, with mild seroma being the most common.

Complex Upper Respiratory Tract (URT) Disorders:
• 43% of horses had coexisting URT abnormalities at diagnosis, and 36.7% of those with postoperative URT issues were found to have multiple disorders.
• These findings suggest the dynamic and multifactorial nature of airway obstructions.

Variation in Individual Responses:
• iDDSP affected individual horses differently; 25% did not show a preoperative decline in PI, and 49% did not experience slower racing speeds before surgery.
• Some horses displaced intermittently and could self-correct during exercise, possibly mitigating performance impairments.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Tongue ties do not widen the upper airways in racehorses

A

This study evaluates the effects of tongue ties on upper airway dimensions and their potential role in managing dorsal displacement of the soft palate (DDSP) in Thoroughbred and Standardbred racehorses.
Findings challenge the long-standing assumption that tongue ties improve upper airway function during exercise.

Key Findings
• Contrary to expectations, tongue ties reduced the pharyngeal diameter during exercise in 93% of horses studied.
• This reduction is inconsistent with the theory that tongue ties prevent tongue retraction and subsequent narrowing of the pharynx.
• Tongue ties had minimal effects on laryngeal dimensions:
-No significant changes were observed in maximum laryngeal width or area.
-Small increases were noted in the relative aperture angle and width at two-thirds of the height, but these changes were not clinically significant.
• DDSP occurred more frequently with a tongue tie (4 cases) than without (1 case) in this small study population.
• Horses familiar with tongue ties did not show improved airway function compared to those naïve to their use.
• Previous exposure to tongue ties also did not influence pharyngeal diameter during exercise.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

The impact of grade of laryngeal function immediately prior to laryngoplasty and ipsilateral ventriculocordectomy on postoperative performance: 623 Thoroughbred racehorses (1998-2013)

A

Investigates whether the preoperative laryngeal function grade influences postoperative outcomes in Thoroughbred racehorses undergoing laryngoplasty and ipsilateral ventriculocordectomy (LPVC).
Focuses on likelihood of postoperative racing, time to first race, racing career longevity, and earnings per start.

Preoperative Grade Influences Likelihood of Racing:
• Horses with grade III.2/III.3 laryngeal function were significantly more likely to race postoperatively compared to grade IV horses.
• Grade III.1 horses showed no significant difference in likelihood of racing compared to grade IV horses, potentially due to the smaller sample size in the grade III.1 group.

Time to First Race Post-Surgery:
• Grade III.2/III.3 horses returned to racing sooner than grade IV horses.
• The extended recovery period for grade IV horses might reflect greater severity of preoperative dysfunction or differences in training readiness.

Career Longevity and Earnings:
• Grade IV horses had greater career longevity (more postoperative races) than grade III.2/III.3 horses.
• No significant differences in postoperative earnings per start were observed between the laryngeal function grades, suggesting equivalent financial returns across grades for horses that did race.

Role of Preoperative Racing Experience:
• Horses with prior racing experience had higher postoperative earnings compared to horses that did not race before surgery.
• This might indicate that experienced horses were already better performers or had greater investment in their careers.

Postoperative Laryngeal Function:
• No evidence was found to support the theory that residual arytenoid movement (grade III) negatively impacts surgical outcomes compared to complete paralysis (grade IV).
• Arytenoid collapse during exercise, observed in grade III.3, underscores the progressive nature of recurrent laryngeal neuropathy (RLN).

Clinical Implications
• Performing LPVC on horses with grade III laryngeal function (especially III.2/III.3) appears justified, as these horses showed better postoperative outcomes compared to grade IV horses.
• Early intervention before complete arytenoid paralysis might optimize outcomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Equine dental sinusitis- A statistical analysis of the effect of antibiotics on dental sinusitis following dental extraction

A

No Significant Impact of Antibiotics:
• Statistical analysis revealed no significant difference in success rates between horses treated with or without antibiotics (p = 0.85).
• 62.5% of horses receiving antibiotics achieved success after the first treatment compared to 60% of those without antibiotics.
• The majority of horses (88.1%) achieved eventual recovery, primarily with the combination of dental extraction and non-steroidal anti-inflammatory drugs (NSAIDs).
• Removal of the primary source of infection (diseased tooth) appears sufficient to resolve inflammation and infection in most cases.

Challenges with Antibiotic Efficacy:
• Issues like limited antibiotic penetration into inflamed sinus tissues and bacterial biofilm formation reduce the effectiveness of antibiotics.
• In chronic sinusitis, mucosal thickening further limits drug efficacy, emphasizing the need for mechanical resolution of the infection.

Minimally Invasive Techniques:
• Standing oral extraction was the primary treatment method, highlighting its effectiveness and minimal invasiveness.
• More invasive approaches, such as trephination, were required in only 12% of cases, and their use should be reserved for specific indications.

32
Q

Clinical outcome of horses with guttural pouch infection following transpharyngeal fenestration

A

The study evaluates the clinical outcomes of horses treated with transpharyngeal diode laser fenestration for chronic guttural pouch infections.
Focuses on the effectiveness of this minimally invasive surgical technique in resolving clinical signs and facilitating long-term recovery.

• The majority of horses (12 out of 13) achieved full resolution of nasal discharge and coughing following fenestration.
• Persistent mild clinical signs in one horse were attributed to concurrent equine asthma rather than unresolved guttural pouch infection.
• Fenestration improved egress of purulent debris, addressing the primary mechanism of infection persistence.
• Surgical intervention likely mitigated chronic inflammation, restored mucociliary clearance, and modified the guttural pouch microenvironment to inhibit bacterial colonization.
• All owners reported satisfaction with the surgical outcomes and postoperative management.
• The absence of significant perioperative complications and the resolution of longstanding clinical signs contributed to positive feedback.

33
Q

Laryngeal reinnervation using the spinal accessory nerve: Electromyographic study of the sternomandibularis muscle

A

The study investigates the potential of the ventral branch of the spinal accessory nerve (SAN) as a donor nerve for laryngeal reinnervation in horses with recurrent laryngeal neuropathy (RLN).
Evaluates muscle activity patterns and fiber recruitment in the sternomandibularis (SM) muscle, highlighting its relevance to the cricoarytenoideus dorsalis (CAD) muscle.

Potential Advantages of the Spinal Accessory Nerve (SAN):
• SAN showed strong activation during inspiration at gallop, aligning with the respiratory cycle.
• Recruitment of type I (slow-twitch, fatigue-resistant) muscle fibers suggests its suitability for sustained activity.
• Activity increased with speed, indicating adaptability to varying respiratory demands during exercise.
Comparison with C1-C2 Nerve:
• Unlike the C1-C2 nerve, SAN stimulation can occur at rest, such as during grazing, potentially reducing CAD muscle atrophy during rehabilitation.
• C1-C2 nerve primarily recruits type II fibers, leading to CAD muscle fatigue, while SAN’s emphasis on type I fibers promotes endurance and sustained function.
Rehabilitation Implications:
• SAN stimulation during natural behaviors (e.g., grazing) may maintain minimal CAD muscle activity even without formal exercise.
• EMG findings suggest that rehabilitation programs emphasizing low-head postures (e.g., grazing or feeding from the ground) could enhance muscle recovery.
Phasic Stimulation Enhances Fatigue Resistance:
• The phasic nature of SAN stimulation (active during inspiration, inactive during expiration) may optimize blood flow and reduce metabolic fatigue in the grafted CAD muscle.
• This intermittent activation allows recovery between contractions, promoting muscle endurance during prolonged exertion.

34
Q

Inspiratory muscle training and testing: Rationale, development and feasibility

A

• The study introduces and evaluates a novel inspiratory muscle training (IMT) and testing protocol for horses, aiming to explore its feasibility, safety, and preliminary effects.
• Focuses on the potential benefits of IMT as a non-invasive strategy to improve respiratory function and potentially enhance equine performance.

Feasibility of Inspiratory Muscle Training:
• IMT was well-tolerated in the majority of horses.
• The protocol demonstrated ease of implementation within a commercial training establishment.
• Horses adapted to the training mask and equipment, with only one horse failing due to behavioral intolerance.

Improved Inspiratory Muscle Strength (IMS):
• Median inspiratory muscle strength index (IMSi) increased significantly from protocol 1 (27 cm H₂O) to protocol 2 (41 cm H₂O) after training.
• Horses were able to sustain higher inspiratory loads by the end of the program, indicating improved respiratory muscle capacity.
Ceiling Effects in Testing Protocol:
• Some horses reached the upper limit of inspiratory muscle strength testing equipment, suggesting that true IMS might have been underestimated.
• Further refinement of the protocol is necessary to accommodate higher performance levels.

• No Adverse Effects
•implications for URT disease (laryngeal hemiplegia) and performance. Also possibly diagnostic.

35
Q

Association between dynamic upper airway obstructions and fitness parameters in Standardbred racehorses during high-speed treadmill exercise

A

This study examines the effects of dynamic upper airway obstructions (DUAOs) on fitness parameters in Standardbred racehorses.
The findings provide insights into the association between the severity and type of DUAO and key fitness metrics.

• Horses with severe or multiple DUAOs exhibited significantly lower fitness levels compared to those without DUAOs.
• Key parameters such as speed at a heart rate of 200 bpm (V200) and speed at a lactate concentration of 4 mmol/L (VLa4) were reduced in these groups.
• Higher peak lactate concentrations (Lacmax) were observed in horses with multiple DUAOs, suggesting early onset of anaerobic metabolism.
• Mild DUAOs, including medial deviation of aryepiglottic folds (MDAF) and epiglottic entrapment (EE), did not significantly impact fitness parameters.
• These obstructions likely caused minimal airflow restriction, insufficient to impair aerobic capacity.

• Dorsal displacement of the soft palate (DDSP) and nasopharyngeal collapse (NPC) were the most common severe DUAOs.
• The combination of DUAOs, such as DDSP with NPC or MDAF, led to more pronounced fitness impairments, highlighting the additive effects of multiple obstructions.

Aerobic vs. Anaerobic Capacity:
• Severe DUAOs likely impair ventilation and alveolar gas exchange, leading to early hypoxemia and a switch to anaerobic metabolism at lower speeds.
• This results in earlier lactate accumulation and reduced aerobic performance.

36
Q

Topography of the respiratory, oral, and guttural pouch bacterial and fungal microbiotas in horses

A

This study provides a comprehensive characterization of the bacterial and fungal microbiotas in the upper and lower respiratory tracts, as well as oral and guttural pouch regions in healthy horses.
Aims to identify microbial communities across anatomical niches and establish potential links between upper respiratory tract microbiota and lower respiratory tract health.

Microbial Variation by Location:
• Distinct bacterial and fungal communities were observed across different anatomical regions, driven by environmental and physiological factors.
• Bacterial diversity was highest in the nostrils and deep nasal passages, while fungal diversity was prominent in the nostrils.
• The pharynx showed microbial profiles most similar to the proximal and distal trachea, suggesting its role as a potential microbial source for the lower respiratory tract.
Dominant Bacterial Taxa:
• Most abundant bacterial genera included Streptococcus, Nicoletella, Gemella, Actinobacillus, and Moraxella.
• Nicoletella semolina was identified as a commensal rather than a pathogenic species, despite being associated with tracheal inflammation in past studies.
Dominant Fungal Taxa:
• Fungal communities were dominated by Vishniacozyma, Mycosphaerella, and Preussia.
• The fungal composition showed significant overlap across respiratory regions, with less spatial variation compared to bacterial communities.
Pharyngeal and Tracheal Similarities:
• The pharyngeal microbiota closely resembled the tracheal microbiota, reinforcing the hypothesis that the pharynx contributes microbes to the lower airways.
• The presence of microbial “gatekeepers” in the pharynx may influence respiratory health.

37
Q

Prognostic indicators and long-term survival in 14 horses with equine multinodular pulmonary fibrosis

A

This study examines prognostic indicators and survival outcomes for horses diagnosed with EMPF, a progressive interstitial lung disease linked to equine herpesvirus-5 (EHV-5).
Explores clinical presentations, diagnostic findings, and therapeutic interventions, providing insights into disease management and outcomes.

• Fever and tachypnoea were the most common presenting clinical signs and were noted in 13/14 horses (92.9%). All horses had hyperfibrinogenaemia
• All horses examined had pleural irregularities with regions of consolidation reported in 9/11.
• the caudodorsal lung quadrant assigned the highest score grade in 10/14 horses.

• Short-term survival was 57%, with only 14% of cases surviving longer than 6 months after discharge.
• OR short-term survival were higher in horses administered corticosteroids (OR = 0.029, 95% CI 0.002-0.615; P = 0.026). (but others died or were euthanised)
• Severity of thoracic radiographic changes and equine herpesvirus-5 viral loads measured by quantitative PCR in the lung on presentation were not associated with survival time.
• Severity of thoracic radiographic changes was also not correlated to equine herpesvirus-5 viral loads in the lung ante-mortem
• 1 horse surviving- managed on low dose pred

• Two horses were noted to have cardiomegaly on post-mortem examination, presumed pulmonary heart disease (cor pulmonale) secondary to the extensive pulmonary fibrosis.
• On histopathology interstitial fibrosis, type II pneumocyte proliferation and mixed inflammatory cell infiltration were reported. In two cases, eosinophilic, intranuclear inclusion bodies were observed in alveolar macrophages.
• One horse displayed evidence of multi-organ fibrosis with myocardial/endocardial fibrosis and portal to portal hepatic fibrosis noted. The liver of this horse was found to be EHV-5 positive on qPCR

38
Q

Clinical findings and outcome predictors for multinodular pulmonary fibrosis in horses: 46 cases (2009-2019)

A

This study focuses on equine multinodular pulmonary fibrosis (EMPF), an interstitial lung disease linked with equine herpesvirus-5 (EHV-5).
It evaluates clinical, diagnostic, and prognostic factors in EMPF to improve diagnostic accuracy and treatment outcomes.

  • Weight loss and fever were frequent findings in EMPF but were not consistently present in all cases.
  • Lymphopenia and systemic inflammation (e.g., increased fibrinogen and serum amyloid A levels) were consistent features, highlighting their utility in distinguishing EMPF from asthma.
  • Histological and imaging findings revealed hallmark features of EMPF, including interstitial fibrosis and alveolar inflammation.
    Role of Bronchoalveolar Lavage Fluid (BALF):
  • BALF analysis showed significant findings, including macrophage atypia and reduced lymphocyte-to-neutrophil ratios, which are not typical in asthma.
  • Lower lymphocyte-to-neutrophil ratios were associated with poorer outcomes, making this a potential prognostic marker.
  • BALF cytology highlighted differences between EMPF and asthma, such as epithelial necrosis and macrophage phagocytic activity/ atypia, which warrant further evaluation.
    Poor Prognosis and Survival Rates:
  • EMPF was associated with high mortality, with only 24% of horses surviving beyond three months.
  • Lower respiratory rates and higher blood lymphocyte counts were linked with better outcomes but were not statistically significant after multiple comparisons.
  • Corticosteroids improved short-term survival but had no impact on long-term prognosis.
    Role of EHV-5:
  • EHV-5 was frequently detected in BALF and lung tissues, but viral presence alone was not predictive of outcomes.
  • The role of viral load and latency in EMPF progression remains unclear.
    Therapeutic Challenges:
  • Antiviral treatments were inconsistently effective, possibly due to the challenges of addressing latent viral reservoirs.
  • Corticosteroid therapy appeared beneficial for managing inflammation and improving short-term outcomes but could not alter disease progression.

Clinical Implications
Importance of Comprehensive Diagnostics:
* EMPF diagnosis requires a combination of clinical signs, BALF analysis, and imaging. Histopathology is definitive but not always feasible.
* Cytological markers like macrophage atypia and epithelial necrosis in BALF should prompt consideration of EMPF in differential diagnoses.
Differentiating EMPF from Asthma:
* EMPF often mimics asthma in its clinical presentation, but systemic inflammation, macrophage atypia, and neutrophilia in BALF can help distinguish it.
* Acute phase proteins like serum amyloid A could be valuable as first-line tests for distinguishing EMPF from other respiratory conditions.

39
Q

Systematic review of the putative role of herpesviruses in pulmonary fibrosis

A

Role of Gammaherpesviruses in Pulmonary Fibrosis:
• Strong evidence suggests gammaherpesviruses, specifically EHV-5 in horses and Epstein-Barr Virus (EBV) in humans, play a role in initiating or exacerbating pulmonary fibrosis.
• Viral DNA and proteins have been localized to key pulmonary cell types, including alveolar epithelial cells and myofibroblasts, in both EMPF and IPF.

Both conditions exhibit:
• Chronic and progressive pulmonary fibrosis.
• Poor response to anti-inflammatory and antiviral treatments.
• High mortality rates and guarded prognoses.
• Similar histopathological findings, such as interstitial thickening, alveolar wall fibrosis, and fibroblastic foci.

Experimental Models and Pathogenesis Insights:
• EHV-5 has been experimentally shown to induce EMPF in healthy horses, satisfying Koch’s postulates.
• Myofibroblast proliferation and excessive extracellular matrix production are central to fibrosis, likely driven by viral interactions with host immune pathways.

Diagnostic Advances:
• PCR of bronchoalveolar lavage (BAL) fluid has high sensitivity and specificity for detecting EHV-5 in EMPF cases.
• Less invasive diagnostics, such as nasal swabs and blood PCR, have shown promise for routine screening.

Gaps in Research:
• Inconsistent evidence regarding antiviral efficacy (e.g., valacyclovir) in reducing viral load or improving outcomes.
• Limited understanding of viral latency and reactivation mechanisms in EMPF and IPF.
• A lack of experimental IPF models limits translational research for human medicine.

40
Q

An epidemiological overview of the equine influenza epidemic in Great Britain during 2019

A

This study highlights the significant impact of the 2019 equine influenza (EI) epidemic in Great Britain (GB), analyzing the factors contributing to its spread and identifying areas for improvement in disease prevention and control.

Role of Vaccination:
• Vaccinated horses were less severely affected than unvaccinated ones, aligning with vaccine efficacy in reducing clinical severity and viral shedding.
• Only 57% of horses on EI-infected premises were vaccinated, below the herd immunity threshold (70-95%).
• Lapsed vaccination schedules and limited booster doses contributed to inadequate protection, emphasizing the need for six-monthly boosters.
Impact of Horse Movements:
• Movement of horses, including new arrivals and temporary travel, was a major factor in the spread of EI.
• 42% of EI-infected premises reported new arrivals in the two weeks preceding a confirmed case.
• Temporary movements to equine gatherings without mandatory vaccination requirements further amplified risks during the epidemic’s second phase.

The epidemic unfolded in two distinct phases:
• Phase 1 (January–March): Primarily affected southern and central GB; heavily influenced by professional premises with higher vaccination coverage and testing requirements.
• Phase 2 (May–August): Expanded to Wales, northeast England, and Scotland; linked to non-professional premises and equine gatherings with limited biosecurity measures.

Biosecurity Shortcomings:
• Only 23% of infected premises quarantined new arrivals, and just 37% had isolation facilities.
• Sharing of equipment and tack was common, indicating poor internal biosecurity practices.
• Anecdotal evidence of knowingly transporting symptomatic horses highlighted gaps in adherence to biosecurity recommendations.

Virological Insights:
• The circulating strain, Florida Clade 1 (H3N8), raised concerns about vaccine effectiveness due to antigenic drift.
• Surveillance remains critical for detecting new strains and informing vaccine updates.

• The median age of confirmed cases was 5 years
• Sports horses (24%) and Cobs (16%) made up the highest proportions by general horse type and breed. TB 15.5%
• Among confirmed cases 72% were unvaccinated and 18% were vaccinated against EI.

• Nasal discharge, coughing and pyrexia were most often observed and occurred together as the combination of reported signs in 25% of confirmed cases for which clinical signs were reported.

41
Q

Annual booster vaccination and the risk of equine influenza to Thoroughbred racehorses

A

This study investigates equine influenza (EI) outbreaks in four Thoroughbred racing yards in Ireland, focusing on vaccination efficacy, biosecurity practices, and risk factors associated with virus spread.
Highlights vaccine breakdown despite adherence to standard vaccination protocols and identifies areas for improvement in disease management.

• 118 horses (67.8%) had an up-to-date vaccination record of which 27 (33.8%) developed clinical signs
• clinically affected horses had an average time since last vaccination of 253d
• Subclinical infection was identified in 12 horses (10.2%), 11 of which had an up-to-date vaccination record
• The index case(s) on all premises was vaccinated in accordance with the Turf Club rules.
• Vaccine breakdown was observed across all products in 27/80 horses (33.8%) with an up-to-date vaccination record.
• Eighteen of the 27 (66.7%) horses had not received a booster vaccination within the previous 6 months and 10 (37%) horses were due annual booster vaccination at the time of developing clinical signs.

Vaccination Limitations:
• Vaccine breakdown occurred in 34% of horses with up-to-date vaccination records, including index cases in all four premises.
• Young horses early in their vaccination careers were particularly susceptible, with significant risk noted within three months of completing the primary vaccination series.
• No Clade 2 virus was included in vaccines administered during the study, despite its recommendation by the OIE since 2010. (Prequenza was used)

Impact of Booster Frequency:
• Horses without a booster vaccination in the six months preceding the outbreak were disproportionately affected.
• Synchronization of annual booster schedules across racing yards was identified as a potential contributor to the seasonal pattern of EI outbreaks.

Role of Biosecurity Measures:
• Poor biosecurity practices, such as failure to isolate new arrivals and movement of horses between stables, facilitated virus spread.
• Subclinical infections in vaccinated horses played a significant role in introducing EI to resident populations.

Mixing of Partially Immune Populations:
• Disease spread was exacerbated by the mixing of racing horses with breeding or pre-training populations, many of which had inadequate vaccination histories.
• This dynamic underscores the risk posed by suboptimal vaccination compliance across equine populations.

Virus Characteristics:
• The outbreak strain, a Clade 2 virus from the Florida sublineage, demonstrated antigenic differences from vaccine strains, contributing to reduced vaccine efficacy.
• High EI antibody titers observed post-outbreak likely reflected responses to viral challenge rather than pre-existing immunity.

42
Q

Equine influenza vaccination in the UK: Current practices may leave horses with suboptimal immunity

A

This study assesses equine influenza (EI) vaccination practices in the UK, highlighting deviations from datasheet guidelines and their potential impact on immunity.
The findings emphasize challenges posed by inconsistent protocols, vaccine hesitancy, and limited adherence to manufacturer recommendations.

Key Findings
Noncompliance with Vaccination Guidelines:
• A significant portion of UK veterinarians deviated from datasheet recommendations, particularly concerning primary course intervals and booster schedules.
• Over 90% of respondents followed competition rules rather than datasheet guidelines, prioritizing event participation over optimal immune protection.
• This inconsistency risks immunity gaps, increasing the vulnerability of horses to EI outbreaks.
Immunity Gaps:
• Vaccinating foals younger than 6 months, which may impair humoral response due to maternally derived antibodies.
•Extended intervals between second and third vaccinations, contrary to the manufacturer’s advice of a 5-month maximum duration.
• Evidence from outbreaks indicates increased EI susceptibility in horses not vaccinated within six months of exposure.
Adverse Drug Reactions (ADRs):
• 65.5% of respondents encountered ADRs, most commonly transient swelling, lethargy, and pyrexia.
• Despite this, underreporting was prevalent, with only 19.1% of ADRs formally documented, limiting feedback to manufacturers and regulatory bodies.
Vaccine Hesitancy:
• Vaccine hesitancy was reported by 86.4% of respondents, frequently linked to owner concerns about over-vaccination, costs, and ADRs.
• This mirrors trends in human and other veterinary contexts, where perceived risks and mistrust influence vaccination uptake.
Challenges with Vaccine Choice:
• Veterinarians often lacked autonomy in vaccine selection, with decisions influenced by corporate policies or cost considerations.
• Differences in antigenic composition between products hinder compliance with the OIE’s recommendations for updated EI strains.
Effects of the 2019 EI Outbreak:
• Following the 2019 outbreak, 63.2% of respondents permanently altered vaccination protocols, most adopting six-monthly boosters.
• This adjustment reflects growing awareness of waning immunity with time since vaccination.

43
Q

Environmental persistence of equid herpesvirus type- 1

A

This study investigates the persistence of Equid Herpesvirus Type-1 (EHV-1) in different environmental conditions and on various materials commonly found in equine housing environments.
Findings provide insights into EHV-1’s environmental survival and practical recommendations for infection control.

Key Findings
• EHV-1 remained viable for up to 48 hours across all tested material-environment combinations.
• Significant reductions in viable virus occurred within the first 3 hours, but the virus persisted long enough to pose a transmission risk.
Impact of Environmental Conditions:
• The outdoor setting had the greatest impact on reducing EHV-1 persistence, likely due to factors such as ultraviolet (UV) light exposure and temperature fluctuations.
• Persistence reduced more rapidly outdoors compared to indoor and refrigerated conditions.
• EHV-1 survived longer indoors, as conditions were more stable and lacked UV exposure.
• The virus showed the highest persistence in refrigerated conditions, emphasizing the protective effect of low temperatures on viral survival.

44
Q

Effect of dexamethasone on antibody response of horses to vaccination with a combined equine influenza virus and equine herpesvirus-1 vaccine

A

The study investigates the impact of dexamethasone, a commonly used corticosteroid, on antibody responses in horses vaccinated against equine influenza virus (EIV) and equine herpesvirus-1 (EHV-1).
Examines the modulation of the immune response by single and multiple doses of dexamethasone and explores implications for clinical practice.

Key Findings
• Only horses in group 2 showed a significant increase in serum SAA levels measured at 72 hours after vaccination (P = .04).
• The SAA levels of horses in group 3 and 4 that received dexamethasone at the time of vaccination were not significantly different from those of the control horses at 72 hours (P > .05).
• There was no statistically significant difference (P > .05) between the serum SAA levels between group 3 (single dose of dexamethasone) and group 4 (multiple doses of dexamethasone).
• Significantly increased mean antibody titers after vaccination were only noted against EIV and only after the vaccination alone (P = .02) and the single dose dexamethasone (P = .01)
• not after multiple doses of dexamethasone (P > .05).

Antibody Responses to EHV-1:
• No significant increase in antibody titers against EHV-1 was observed in any group, regardless of dexamethasone treatment.
• This aligns with the possibility that repeat vaccination may not elicit a strong secondary response in previously vaccinated horses, as protection against EHV-1 may rely more on cellular immunity.
Variable Effects of Dexamethasone:
• The observed effects of dexamethasone on immune response were antigen-specific and dose-dependent.
• The immune modulation by dexamethasone appeared complex, potentially influencing antibody subtype production and antigen presentation pathways.

45
Q

Vaccination for the prevention of equine herpesvirus-1 disease in domesticated horses

A

The paper systematically reviews and evaluates the efficacy of vaccines against equine herpesvirus-1 (EHV-1) in domesticated horses.
Focuses on key outcomes like pyrexia, abortion, neurologic signs, viremia, and nasal shedding.

Key Findings
* Overall, vaccination minimally reduced the incidence of clinical disease associated with EHV-1.
* Publication bias was noted for several outcomes, indicating potential overestimation of vaccine benefits in published studies.
* Moderate to high risk of bias was observed due to issues like small sample sizes, lack of blinding, and inconsistent reporting.

Summary of findings
* Pyrexia: (25%) trials reported that vaccination was significantly associated with a reduced frequency of pyrexia in EHV-1 infected horses.
- A pooled estimate of the relative risk of pyrexia following vaccination of 0.468
- The between-trial heterogeneity was severe
- Some reduction in incidence, particularly with MLV vaccines.
* Abortion: only 1/6 (17%) vaccine trials reported that vaccination was significantly associated with a reduced frequency of abortion in EHV-1-infected horses.
-A pooled estimate of the relative risk of abortion following vaccination of 0.410
-which suggested that vaccination offered no benefit in the prevention of abortion
* Neurologic signs: .none of the vaccine trials (0/10) reported that vaccination was significantly associated with a reduced frequency of neurologic signs in EHV-1-infected horses
- A pooled estimate of the relative risk of ataxia and other neurologic signs following vaccination of 0.964
* Viraemia: Overall, 4/38 (10.5%) trials reported that vaccination was significantly associated with a reduced frequency of cell-associated viremia in EHV-1-infected horses.
-A pooled estimate of the relative risk of viremia following vaccination of 0.590
-The between-trial heterogeneity was severe
-MLV vaccines reduced the frequency of cell-associated viremia to some extent, but results were inconsistent (heterogeneity remained severe)
* Nasal shedding: Overall, 2/32 (6.3%) trials reported that vaccination was significantly associated with a reduced frequency of nasal shedding in EHV-1 infected horses.
-A pooled estimate of the relative risk of nasal shedding following vaccination of 0.661
- significant publication bias.
- The between-trial heterogeneity was severe
-Our results suggest that MLV vaccines may decrease the incidence of nasal shedding in horses; however, the high degree of heterogeneity in these studies indicates that these results should be interpreted with caution. Neither killed virus products nor other types of experimental vaccines significantly altered the incidence of nasal shedding in EHV-1-infected horses

46
Q

Viremia and nasal shedding for the diagnosis of equine herpesvirus-1 infection in domesticated horses

A

Sensitivity of Nasal Shedding and Viremia Detection:
* 60 experimental and 20 observational studies met inclusion criteria.
* In experimental studies the sensitivity of qPCR matched or exceeded that seen for virus isolation from either nasal secretions or blood.
* Detection of nasal shedding typically occurred within 2 days after EHV-1 inoculation with a detection period of 3 to 7 days.
* Viremia lasted 2 to 7 days and was usually detected ≥1 days after positive identification of EHV-1 in nasal secretions.
* Nasal shedding and viremia decreased over time and remained detectable in some horses for several weeks after inoculation

Viremia Detection
Comparative Sensitivity of qPCR vs Virus Isolation:
* qPCR matched or exceeded virus isolation sensitivity in all experimental studies.
qPCR had:
* 100% sensitivity in detecting nasal shedding in several studies where virus isolation failed.
* Longer duration detection for nasal shedding (up to 21 days) compared to virus isolation (up to 9 days).
* Longer duration detection of viremia (up to 30 days) compared to virus isolation (up to 14 days).

Temporal Dynamics of Detection:
* Nasal shedding was typically detectable within 2 days post-infection, persisting for 3–7 days in most cases.
* Viremia onset followed nasal shedding and lasted for 2–7 days but could remain detectable for several weeks in some cases.
Diagnostic Methods:
* Quantitative PCR (qPCR) was more sensitive than traditional virus isolation methods for both nasal shedding and viremia.
* Virus isolation showed variable sensitivity, particularly in experimental studies using different EHV-1 strains and inoculation methods.
Factors Influencing Detection:
* Sampling frequency and timing were critical for accurate detection of EHV-1, particularly for short-lived viremia and nasal shedding.
* Variability in diagnostic outcomes was observed depending on strain virulence, infection dose, and route of inoculation.

Clinical Implications
Diagnostic Recommendations:
* Nasal swabs are preferred for detecting EHV-1, especially in clinical settings where sampling can occur early in the disease course.
* Blood samples should complement nasal swabs to enhance detection sensitivity, particularly in cases of EHM or systemic infection.

47
Q

Pharmacologic interventions for the treatment of equine herpesvirus-1 in domesticated horses: A systematic review

A

Limited Efficacy of Pharmacological Agents:
* Most pharmacological interventions showed minimal or no significant benefits in reducing clinical signs, viremia, or nasal shedding.
* Valacyclovir and small interfering RNAs (siRNAs) were among the better-studied agents but had limited success in clinical or virological outcomes.
Variability in Outcomes Across Studies:
* Variability in drug efficacy was influenced by factors like dosing schedules, timing relative to infection, and study designs.
* Neurological signs (equine herpesvirus myeloencephalopathy, EHM) and abortion rates were rarely mitigated by the treatments studied.
Challenges with Study Quality:
* Moderate to high risk of bias was identified in most studies due to small sample sizes, inconsistent reporting, and lack of blinding.
* Many studies lacked standardization in methodologies, including viral challenge models and outcome measures.

Specific Findings by Drug Class:
* Antivirals (e.g., Valacyclovir): Reduced viremia levels in some studies but showed no consistent effect on clinical signs or nasal shedding.
* siRNAs: Showed potential for reducing specific neurological outcomes in isolated studies but lacked reproducibility across trials.
* Parapoxvirus ovis-based Immunomodulators: Minimal impact on clinical or virological outcomes.
* Other Agents (e.g., Interferons, Herbal Products, Heparin): Failed to demonstrate significant benefits in reducing EHV-1-related clinical signs or infection rates.

  • Valacyclovir and related antivirals may offer some benefits in reducing viremia, particularly when administered prophylactically or early post-infection.
    -Their high cost and limited efficacy necessitate careful consideration of their use in clinical practice.
  • Future trials must standardize protocols, include larger sample sizes, and employ blinded, randomized designs to enhance reliability.
  • Long-term studies are needed to evaluate the potential of therapies in preventing latent infection and reactivation.
48
Q

Multifocal outbreak of equine influenza in vaccinated horses in Argentina in 2018: Epidemiological aspects and molecular characterisation of the involved virus strains

A

This study investigates the 2018 outbreak of equine influenza (EI) in Argentina, emphasizing the epidemiological aspects, molecular characterization of the involved virus strains, and evidence of vaccine breakdown.
Highlights the challenges of controlling EI, even in vaccinated equine populations, and underscores the need for updated vaccination protocols.

• The outbreak occurred despite vaccination compliance, with 61% of affected horses having up-to-date vaccination records.
• Most horses were vaccinated with a vaccine containing the outdated A/eq/Kentucky/1997 strain, which is phylogenetically distant from the circulating 2018 Florida clade 1 strains.
• Amino acid differences in the haemagglutinin (HA) protein, particularly at antigenic sites, were identified as potential contributors to vaccine failure.
• The 2018 strains belonged to the Florida clade 1 sublineage and were genetically related to strains from Chile (2018), Scotland (2018), and earlier isolates from the USA (2016) and Japan (2017).
• These findings suggest that the outbreak likely originated from the introduction of infected horses from Chile, given frequent cross-border equine movement.

Clinical and Serological Observations:
• Horses vaccinated with updated strains experienced milder clinical signs or remained asymptomatic despite exposure, suggesting partial protection.
• Antibody levels varied among affected horses, with a significant proportion displaying moderate to high titres, indicating recent EIV exposure.
Role of Horse Movement and Events:
• The unrestricted movement of horses for competitions and events significantly contributed to the virus’s rapid spread across six provinces in Argentina.
• The lack of stringent quarantine measures exacerbated the outbreak’s scope.
Strain Evolution:
• The genetic differences between the 2012 and 2018 Argentinian strains suggest an independent reintroduction of the virus rather than local evolution.

49
Q

Antigenic differences between equine influenza virus vaccine strains and Florida sublineage clade 1 strains isolated in Europe in 2019

A

The study investigates the antigenic differences between equine influenza virus (EIV) vaccine strains and Florida sublineage clade 1 (Fc1) strains responsible for European outbreaks in 2019.
Evaluates vaccine efficacy against evolving Fc1 strains using neutralization tests and reverse genetics.

Antigenic Divergence of 2019 Strains:
• Amino acid substitutions in haemagglutinin (HA) proteins of 2019 Fc1 strains (e.g., A/equine/Tipperary/1/2019 and A/equine/Essex/1/2019) contribute to antigenic divergence from the vaccine strains A/equine/South Africa/4/2003 and A/equine/Ibaraki/1/2007.
• These substitutions were found in critical antigenic sites (e.g., sites A, B, and C), affecting cross-reactivity.
Neutralization Test Results:
• Antibody titers against the 2019 strains were 2.5–6.3 times lower than those against homologous vaccine strains, indicating reduced vaccine efficacy.
• Recombinant viruses (reverse genetics-derived) performed similarly to wild-type strains, validating their utility for cross-neutralization assays.
Vaccine Protection Despite Divergence:
• Despite reduced neutralizing antibody titers, vaccinated horses exhibited significantly milder clinical signs or asymptomatic infection compared to unvaccinated controls during outbreaks.
• Suggests partial protection from current vaccines but underscores the necessity of updating vaccine strains to improve efficacy.

Spread of Fc1 Strains:
• The 2019 European strains are closely related to those identified in the Americas and Africa in 2018–2019, highlighting the rapid global spread of Fc1 strains.
• These findings emphasize the importance of ongoing international surveillance.

• Vaccine Updates Are Essential: Current vaccines containing Fc1 strains like South Africa/2003 or Ibaraki/2007 may provide insufficient protection against recent Fc1 variants.

50
Q

Growth properties and immunogenicity of a virus generated by reverse genetics for an inactivated equine influenza vaccine

A

The study evaluates the growth characteristics and immunogenicity of a reverse genetics (RG) virus created as a candidate for equine influenza (EI) vaccine strains.
The RG virus combines genes from the A/equine/Ibaraki/1/2007 (H3N8) strain and a high-growth human influenza virus backbone.

High Growth Properties in Eggs:
• The RG virus exhibited strong growth in embryonated chicken eggs, comparable to or slightly exceeding the growth of the wild-type (WT) strain.
• The high-yield human influenza virus backbone provided efficient replication, making the RG virus suitable for vaccine production.

Immunogenicity:
• Unvaccinated Yearlings:
-Initial vaccination elicited a weak immune response, but subsequent vaccinations significantly boosted antibody levels.
-After the second vaccination, the haemagglutination inhibition (HI) titres reached levels comparable to the WT vaccine group.
• Vaccinated Adults:
-Horses with prior vaccinations showed little response to a booster dose, maintaining pre-vaccination antibody levels, which were already high.
-No significant differences in HI titres were observed between the RG and WT vaccine groups.

Practical Benefits of RG Techniques:
• RG methods allow for rapid generation of vaccine strains using only the genetic sequence of the desired virus.
• This approach eliminates the need for physical virus isolates, particularly beneficial for regions free from equine influenza, like Japan.

51
Q

Risk factors for duration of equine rhinitis A virus respiratory disease

A

The study examines risk factors associated with the duration of clinical signs in horses infected with Equine Rhinitis A Virus (ERAV).
Focuses on demographic, serologic, and contact network metrics within a training facility to better understand disease dynamics and management.

Duration of Clinical Disease:
• Wide variation observed, ranging from 1 to over 40 days, with a median recovery time of 6 days.
• Chronic cases were associated with missed training days, financial impacts, and delayed race preparation.
Birth Month as a Significant Factor:
• Late-born yearlings (April–May) had longer durations of illness compared to early-born counterparts (February–March).
• Hypothesized that late-born yearlings might have less mature immune systems due to younger age at the start of training.
No Significant Impact of Contact Network Metrics:
• Degree, betweenness, and eigenvector centrality did not correlate with disease duration.
• High contact rates across the facility might have minimized variability in exposure, masking potential effects of network metrics.

• Yearling attack rate for infectious respiratory disease was 87.9% (n = 51). 55% in the total population.
• Only 2 mature rachehorses became clinically diseased.
• Clinical disease was characterised by mucopurulent nasal discharge (100% of cases), acute intermittent cough (37.7%) and ocular discharge (62.3%). Fever (>38.5 ) and inappetence were rarely reported (15.2 and 3.8% respectively)
• Occurrence of seroconversion to ERAV, or a baseline titre of >512:1 in prevalent cases, was 75% (n = 27) among clinically ill yearlings. Among yearlings seropositive for ERAV, 8.3% (n = 3) also seroconverted to EHV-1/4 indicating a co-infection (did not impact disease duration)
• In those yearlings born February–May, birth month was significant in the Cox proportional hazard model (Hazard Ratio 0.7, 95% CI 0.49–1, P = 0.05).

52
Q

Chlamydia psittaci infection as a cause of respiratory disease in neonatal foals

A

Severe Respiratory Disease in Neonatal Foals:
• All foals exhibited acute respiratory distress, consistent with Equine Neonatal Acute Lung Injury (EqNALI) or Equine Neonatal Acute Respiratory Distress Syndrome (EqNARDS). (PaO2/FiO2 < 140-200mmHg)
• Only 2 of 15 foals survived; the remaining succumbed to respiratory failure within hours of hospitalization.
Common post-mortem findings:
• Severe lung congestion, edema, consolidation, and atelectasis.
• Diffuse interstitial and bronchoalveolar pneumonia.
• Cellular debris and inflammatory infiltrates, including neutrophils and macrophages.
Radiographic findings: Bilateral interstitial or alveolar patterns in foals that underwent imaging.

Diagnostic Insights:
• PCR detected C. psittaci in nasal swabs, rectal swabs, lung parenchyma, and fetal membranes.
• Antemortem molecular diagnostics and post-mortem histopathology provided definitive diagnosis.

Infection Source and Zoonotic Potential:
• Likely sources: In utero infection, peri-parturient exposure, or spillover from avian species.
• Zoonotic risk highlighted by prior cases of human psittacosis linked to equine abortions.

• C. psittaci should be considered in neonatal foals presenting with severe respiratory distress, especially in regions with reported cases or farms with abortion histories.
• Veterinarians and handlers should use Personal Protective Equipment (PPE) when managing suspected or confirmed cases to minimize zoonotic transmission risks.

• Empirical antimicrobial regimens may not cover C. psittaci, an obligate intracellular bacterium.
• Oxytetracycline, doxycycline, and rifampin combinations may be more effective but were not widely employed in this study.
• Standard respiratory support, including oxygen therapy, proved insufficient in many cases. Mechanical ventilation and inhalational treatments might provide additional benefits but were not utilized.

53
Q

Acute interstitial pneumonia in foals: A severe, multifactorial syndrome with lung tissue recovery in surviving foals

A

• No single causative pathogen identified; a combination of bacterial, viral, and opportunistic infections likely contributed.
• Common pathogens detected:
-Bacterial: Escherichia coli, Rhodococcus equi, Klebsiella pneumoniae.
-Viral: Equine herpesvirus (EHV-2, EHV-4, EHV-5).
-Opportunistic: Pneumocystis carinii identified in all acutely affected foals.

Clinical Course:
• Acute phase: Severe respiratory distress with high fever, tachypnea, and radiographic evidence of diffuse alveolar and interstitial patterns.
• Recovered foals: Improved lung function with histological evidence of healing, including mild inflammation and normal alveolar architecture.

Pathological Findings:
• Acute Phase: Extensive parenchymal collapse, necrosis, and interstitial inflammation. Viral inclusions and syncytial cells consistent with EHV infections. Opportunistic fungal and bacterial structures identified in some foals.
• Recovery Phase: Histological normalization of lung tissue with no persistent fibrosis or structural damage. Suggests that lung parenchyma can fully regenerate following AIP.

Environmental and Immunological Factors:
• Pathogen endemicity at the breeding farm may have contributed to disease onset in immunocompromised foals.
• Declining maternal antibodies and immunosuppressive treatments (e.g., corticosteroids) likely predisposed foals to AIP.

54
Q

Detection of Mycoplasma spp. in horses with respiratory disorders

A

• Overall prevalence in clinical respiratory samples was 16.9%. (horses suspected of resp disease- no further info)
• M. equirhinis was the predominant species, identified in 85% of rt-PCR-positive samples and 98% of cultured isolates.
• Low detection rates for M. felis (2% of cultured strains) and M. pulmonis (1% of rt-PCR-positive samples).

• rt-PCR post-enrichment significantly improved sensitivity compared to culture or rt-PCR without enrichment.

Factors Influencing Detection:
• Breed: Higher prevalence in racing breeds (26%) compared to other breeds (14.8%), likely due to increased exposure, frequent transport, and strenuous exercise.
• Age: Young horses (<5 years) showed higher prevalence in univariate analysis, though not confirmed in multivariate analysis.
• Sample Type: TW had a significantly higher detection rate (19.4%) compared to BAL (8.4%), possibly due to differences in sampling techniques.

55
Q

Hyponatremia in horses with septic pneumopathy

A

Prevalence of Hyponatremia:
• Hyponatremia was present in 57% of horses with septic pneumopathy at admission.
• Frequency decreased to 44% when horses with pleural effusion were excluded, suggesting multiple underlying mechanisms.
Severity of Hyponatremia:
• Most cases were mild (130–134 mmol/L), with moderate (125–129 mmol/L) and severe cases (<125 mmol/L) less common.
• All hyponatremic cases were hypotonic, indicating true hyponatremia rather than pseudohyponatremia.

Hyponatremia correlated with markers of systemic inflammation:
• Increased fibrinogen levels (mean: 461 mg/dL vs. 321 mg/dL in normonatremic horses).
• Higher rectal temperatures (mean: 38.8°C vs. 38.1°C).
• Negative correlations observed between plasma sodium concentrations and fibrinogen (ρ = -0.57) and rectal temperature (ρ = -0.51).
Impact on Hospitalization:
•Hyponatremic horses had significantly longer hospital stays (mean: 9.8 days vs. 5.6 days in normonatremic horses).
• Hyponatremia was more prevalent in horses meeting SIRS criteria at admission (70%).

Potential Mechanisms:
• Nonosmotic antidiuretic hormone (ADH) release due to inflammation and cytokine activity (e.g., interleukin-6) likely contributed to hyponatremia.
• Pleural effusion-related hypovolemia may have led to ADH-mediated water retention and dilutional hyponatremia in some cases.

• While survival was not significantly different between hyponatremic and normonatremic horses, most non-surviving cases were hyponatremic.

56
Q

Utility of serum amyloid A in monitoring clinical response to antimicrobial treatment in horses with bacterial pneumonia

A

• This study evaluates serum amyloid A (SAA) as a biomarker for monitoring clinical response to antimicrobial treatment in horses with bacterial pneumonia. Some horses with inflammatory comorbidities included. n=18. Generally positie outcomes so no association with survival.
• SAA is proposed as a more dynamic and sensitive indicator of disease progression and treatment response compared to traditional markers like white blood cell (WBC) count, neutrophil count, and fibrinogen.

SAA as a Biomarker:
• SAA levels decreased significantly over the treatment course, correlating with clinical improvement.
• Peak SAA concentration occurred at day 2 post-treatment initiation, likely due to a delayed systemic response to antimicrobial therapy.
Comparison with Traditional Markers:
• Plasma fibrinogen, WBC, and neutrophil counts did not show significant changes during treatment, limiting their utility for real-time monitoring.
• SAA was more responsive, making it a valuable marker for assessing treatment efficacy and guiding clinical decisions.

Short-Term Outcomes:
• All horses survived to discharge, and in 94% of cases, SAA levels were lower at discharge compared to admission.
• 39% of horses had normalized SAA levels by the time of discharge, indicating its potential as a discharge criterion.

Correlations:
• No significant correlation between SAA levels and bacterial isolate count or type, suggesting SAA reflects general systemic inflammation rather than pathogen-specific responses.

57
Q

Relationship between tracheobronchoscopic score and bronchoalveolar lavage red blood cell numbers in the diagnosis of exercise-induced pulmonary hemorrhage in horses

A

The study evaluates the relationship between tracheobronchoscopic examination (TBE) scores and bronchoalveolar lavage fluid red blood cell (BALFRBC) counts in diagnosing exercise-induced pulmonary hemorrhage (EIPH) in horses.
Compares diagnostic sensitivities and specificities of TBE and BALFRBC in horses after high-intensity exercise.
No gold standard test-> Bayesian stats

Weak Correlation Between TBE and BALFRBC:
• Statistically significant but weak correlation (Spearman’s r = 0.42) between TBE scores and BALFRBC counts.
• Wide variability in BALFRBC counts within each TBE score, suggesting TBE is not a reliable standalone indicator of EIPH severity.

TBE:
• Sensitivity: 0.59 (95% CI: 0.49–0.68).
• Specificity: 0.99 (95% CI: 0.99–1.00).
• High specificity implies minimal false positives, but low sensitivity highlights frequent false negatives.
BALFRBC:
• Sensitivity: 0.93 (95% CI: 0.88–0.96).
• Specificity: 0.95 (95% CI: 0.73–1.00).
• Higher sensitivity and comparable specificity make BALFRBC a more accurate diagnostic tool for EIPH.
Prevalence of EIPH:
• EIPH prevalence varied based on diagnostic method and exercise intensity:
• TBE: 52% prevalence in barrel racers, 59% in Thoroughbreds.
• BALFRBC threshold of ≥992/µL: 66% prevalence in barrel racers, 96% in Thoroughbreds.
BAL Procedure Effects:
• Performing repeated BALs within 24 hours in sedentary horses showed no increase in RBC counts, confirming that the procedure does not induce airway hemorrhage.
False Negatives in TBE:
• 39 instances where TBE score = 0, but BALFRBC ≥ 992/µL, demonstrating that a negative TBE score cannot reliably rule out EIPH.

58
Q

Training-related risk factors for exercise-induced pulmonary haemorrhage in British National Hunt racehorses

A

The study investigates training-related risk factors for exercise-induced pulmonary hemorrhage (EIPH) in British National Hunt (NH) racehorses.
Explores the prevalence of EIPH based on tracheal blood presence and significant haemosiderophages in tracheal wash (TW) fluid and the relationship between training parameters and EIPH indicators.

Prevalence of EIPH:
• Tracheal blood observed in 7.2% of samples.
• Significant haemosiderophages (≥25% macrophages containing haemosiderin) present in 36% of samples.
• Cytological methods (haemosiderophages) yielded higher EIPH prevalence estimates than endoscopic observation (tracheal blood).

Retained in MV for tracheal blood:
• time in training- OR 1.5
• winter/ spring vs autumn- OR 2.29-2.38
• Male: OR 0.16
• presence of haemosiderophages- OR 5
• Medium (OR10) and high (OR 60) impact work
• yard (0.29-1.04)

Retained in MV for haemosiderophages:
• time in training- OR 1.5
• Winter- 1.9
• Spring- 1.6
• increased neut % TW- OR 2.4-9.7 (>50%)
• recent tracheal blood: OR 3.5
• some yards

• Cytological examination of TW samples is more sensitive for detecting EIPH than tracheobronchoscopy alone.
• Cytology can identify subclinical or prior hemorrhage that is missed by endoscopic visualization.
• Findings support the capillary stress failure theory, where repeated high pulmonary pressures during intense exercise lead to vascular remodeling and increased EIPH susceptibility.
• Inflammation appears to result from hemorrhage rather than causing it, refining the understanding of EIPH progression.

59
Q

Electrical impedance tomography to measure lung ventilation distribution in healthy horses and horses with left-sided cardiac volume overload

A

• The study explores the use of Electrical Impedance Tomography (EIT) to assess lung ventilation distribution in healthy horses and those with left-sided cardiac volume overload (LCVO), both compensated and decompensated.
• Aims to validate EIT as a non-invasive tool to detect pulmonary ventilation abnormalities related to cardiac conditions.

Differences in Ventilation Distribution:
• Horses with LCVO exhibited decreased ventilation in the left lung and increased ventilation in the right lung compared to healthy horses.
• Decompensated LCVO horses had more pronounced dorsal ventilation and less ventral and central-ventral ventilation, consistent with pulmonary edema (PE).
Efficacy of Furosemide Treatment:
• Furosemide administration improved ventilation distribution toward normal patterns in decompensated LCVO horses.
• Post-treatment improvements included increased ventilated area in the left lung (VAL), average maximum impedance change (avg-maxVΔZLLine), and reduced dependent silent spaces (DSS).

EIT successfully identified differences in ventilation distribution associated with LCVO severity.
• Non-conventional EIT variables provided a better differentiation between cohorts than conventional metrics, supporting its utility in detecting subtle changes.

• Findings support the “slinky effect” model, where gravity and pulmonary edema redistribute lung ventilation dorsally in LCVO horses.
• Observations suggest the left lung is preferentially affected in LCVO, possibly due to anatomical or hemodynamic factors.

60
Q

Can bronchoconstriction and bronchodilatation in horses be detected using electrical impedance tomography?

A

electrical impedence tomography, bronchoconstriction

61
Q

Perioperative lung ultrasonography in healthy horses undergoing general anesthesia for elective surgery

A

The study evaluates perioperative lung ultrasonography (LUS) in healthy horses undergoing general anesthesia (GA) for elective surgery.
Investigates LUS findings before and after GA, proposes a LUS scoring system, and examines factors influencing LUS changes.

LUS Findings Post-Anesthesia:
• Significant increase in the number of I-lines, B-lines, and coalescent B-lines after anesthesia compared to pre-anesthesia.
• LUS changes peaked at 2 hours post-anesthesia and returned to baseline within 24 hours for most horses.
Correlation with Anesthetic Factors:
• Prolonged GA and total procedure time were significantly correlated with higher post-anesthetic LUS scores.
• Horses with cardiorespiratory abnormalities (e.g., hypoxemia, hypercapnia) during GA had significantly higher LUS scores.
Regional Variations in LUS Findings:
• Coalescent B-lines were predominantly found in cranioventral regions, while I-lines and B-lines were more common in caudoventral and caudodorsal regions.
Rare Findings:
• Consolidation, irregular pleura, and pleural effusion were uncommon, suggesting their potential as indicators of thoracic disease rather than GA-induced changes.

62
Q

Bronchoalveolar lavage hemosiderosis in lightly active or sedentary horses

A

This study examines the presence of hemosiderophages in the bronchoalveolar lavage fluid (BALF) of lightly active or sedentary horses with suspected respiratory disease.
Aims to determine the association between hemosiderophages and severe equine asthma (sEA) and explore potential underlying mechanisms.

Prevalence of Hemosiderophages:
• Hemosiderophages were identified in 55% of horses studied.
• 62% of hemosiderophagic horses had mild hemosiderophages (<20% of alveolar macrophages), while 10% had severe hemosiderophages (>50% of alveolar macrophages).
Association with Severe Equine Asthma:
• Horses diagnosed with sEA were significantly more likely to have hemosiderophages than those with mild-to-moderate equine asthma (mEA):
-Odds Ratio (OR) = 11.1, 95% CI: 3.2–38.5, P < 0.001.
• No significant association was found between hemosiderophages and other cardiopulmonary diseases.

Clinical Features:
• Higher respiratory rates and complaints of tachypnea were more frequent in hemosiderophagic horses but were not independently predictive in multivariate analysis.
• Cytological markers of airway inflammation (e.g., neutrophils, mast cells) were not significantly associated with hemosiderophages, suggesting a decoupling of inflammation and pulmonary bleeding in chronic cases.

• In horses with mEA, 71.8% had no hemosiderophages observed on PPB, and 12.8% had grade 1 (mild), whereas equal frequencies (7.7%) of grade 2 (moderate) and grade 3 (marked) were noted.
• In horses with sEA, 19% had no hemosiderophages observed, with 59.5% having grade 1, 14.3% grade 2, and 7.1% grade 3.

Mechanisms of Hemosiderophages in Sedentary Horses:
• Pulmonary hypertension secondary to sEA, leading to alveolar hemorrhage.
• Chronic inflammation and oxidative stress impairing pulmonary microcirculation.
• Prolonged hemosiderophage retention in the lungs due to slow clearance rates (2 weeks to >1 year).

63
Q

Effects of 2 modes of positive pressure ventilation on respiratory mechanics and gas exchange in foals

A

This study compares continuous positive airway pressure (CPAP) and pressure support ventilation (PSV) in their effects on respiratory mechanics and gas exchange in sedated foals with pharmacologically induced respiratory insufficiency.
Key focus areas include ventilation-perfusion (V/Q) matching, pulmonary aeration, and the safety and feasibility of these ventilation modes.

Efficacy of CPAP and PSV:
• Both CPAP and PSV improved arterial oxygen pressure (PaO₂) and ventilation-perfusion matching (decreased Enghoff’s index).
• CPAP showed greater improvement in oxygenation compared to PSV at the highest pressure settings (T3 phase).
• No adverse effects on arterial carbon dioxide pressure (PaCO₂) were observed with either mode, even at higher pressure settings.
Pulmonary Aeration and Lung Volumes:
• Computed tomography (CT) demonstrated increased lung volumes and decreased attenuation in dependent lung fields, indicating improved pulmonary aeration.
• CPAP was associated with greater recruitment of collapsed alveoli compared to PSV.
Respiratory Mechanics:
• Both ventilation modes reduced respiratory rate (RR) and increased tidal volume (TV), reflecting more efficient ventilation.
• Improved peak inspiratory flow (PIF) and reduced work of breathing were noted during both modes.
Safety and Tolerance:
• Both modes were well-tolerated by all foals, with no adverse effects on heart rate, blood pressure, or overall clinical status.
• Periods of apnea were more frequent during CPAP, likely due to activation of airway stretch receptors or the Hering-Breuer reflex, but these events were managed effectively by switching to PSV.
Hypercapnia and Dead Space:
• Contrary to the hypothesis, higher airway pressures did not increase physiological dead space or cause hypercapnia, suggesting no overdistension of healthy lung tissue.

Clinical Implications
• CPAP is more effective for oxygenation improvement and alveolar recruitment, making it preferable for foals with hypoxemia and mild respiratory insufficiency.
• PSV may be better suited for foals requiring greater ventilatory support due to fatigue or respiratory drive failure.
• Both CPAP and PSV can be implemented as non-invasive ventilation strategies, eliminating the need for tracheal intubation and its associated risks.
• Findings confirm that airway pressures up to 20 cmH₂O are safe for healthy foals, avoiding risks of lung overdistension and reduced cardiac output.

64
Q

The efficacy of N-acetylcysteine in decreasing airway inflammation and mucus accumulation in horses with 18 hours of head confinement

A

• The study evaluates the efficacy of oral N-acetylcysteine (NAC) in reducing airway inflammation and mucus accumulation in horses subjected to 18 hours of head confinement, mimicking transport conditions.
• NAC’s mucolytic, antioxidant, and anti-inflammatory properties are highlighted as potential benefits in mitigating respiratory complications during prolonged head restraint.

Impact of NAC on Mucus Accumulation:
• Horses in the confined head (CH) condition without NAC showed significant mucus accumulation in the lower airways, as evidenced by elevated endoscopic mucus scores (grades 2 and 3).
• NAC administration significantly reduced mucus scores, with only mild accumulation observed in two horses (grade 2) and none in the others.
Reduction of Airway Inflammation:
• Bronchoalveolar lavage fluid (BALF) analysis revealed marked reductions in total cell count and neutrophil count in the NAC-treated group compared to the CH group.
• NAC reduced the neutrophil percentage and inflammatory markers in the BALF, demonstrating its anti-inflammatory effects.

Safety and Feasibility:
• NAC was well-tolerated by all horses, with no adverse effects reported.
• Oral administration proved practical and effective, making it a viable option for equine care.

65
Q

Conservation of vaccine antigen sequences encoded by sequenced strains of Streptococcus equi subsp. equi

A

The study explores the genetic conservation of vaccine antigen sequences, specifically focusing on the eight antigens included in the Strangvac vaccine.
Highlights the significant conservation of these antigens across global Streptococcus equi (S. equi) isolates, emphasizing their potential effectiveness in diverse equine populations.

Conservation of Vaccine Antigens:
• The eight antigens used in Strangvac are highly conserved across 759 S. equi genomes collected from 19 countries between 1955 and 2018.
• All genomes encoded identical sequences for at least six antigens, with 98% of genomes encoding all eight antigens with no or minimal variation.
• The high conservation contrasts with the variability observed in the SeM protein, an immunodominant antigen in natural S. equi infections.
• at least 1579 (99.9%) of 1580 amino acids in Strangvac were identical in 743 (97.9%) genomes, and all genomes encoded identical amino acid sequences for at least six of the eight Strangvac antigens

Minor Variations Identified:
• Seven nonsynonymous amino acid changes were identified across seven positions in the eight antigens.
• Truncations or deletions affecting one or more antigens were observed in only 1.8% of genomes, typically associated with strains from persistently infected horses or geographically isolated regions.
Geographical and Population-Level Findings:
• Variations were slightly more prevalent in isolates from regions like Argentina, Australia, and the UAE, but these represented a minor fraction of the overall dataset.
• Despite minor variations, the high degree of conservation supports the global applicability of Strangvac.

Variability in SeM Protein:
• The SeM protein exhibited significant diversity, with 111 distinct alleles identified across the genome collection.
• SeM variability likely results from selective immune pressure during natural infections, underscoring the challenge of developing SeM-based vaccines.

Functional Implications of Antigen Conservation:
• The inclusion of multiple conserved antigens in Strangvac reduces the likelihood of immune escape through mutation or selective pressure targeting a single antigen.
• Conservation of these antigens is attributed to functional constraints critical to bacterial fitness, limiting their variability compared to SeM.

66
Q

Plasma lipidome of healthy and Rhodococcus equi‐infected foals over time

A

Age-Related Lipidome Changes:
• primarily during the first week of life.- adaptations to extrauterine life, transitioning from colostrum to milk, and ongoing developmental processes.
• Phosphatidylcholines (PCs) and phosphatidylethanolamines (PEs), major components of cell membranes, showed significant changes, reflecting developmental and metabolic adaptations.

Infection-Induced Lipidome Alterations:
• Subclinical foals exhibited lipidome profiles suggestive of effective inflammatory and healing responses, including elevated anti-inflammatory fatty acids like EPA and DHA.
• Clinical foals had fewer lipid changes, primarily involving glycerophospholipid metabolism, indicating a potential inability to mount effective responses.

Lipidomics as a Diagnostic Tool:
• Lysophosphatidylcholines (LPCs) were significantly reduced in infected foals, similar to patterns observed in human tuberculosis.

Lipid Classes and Pathways:
• Glycerophospholipids, triglycerides, and sphingolipids dominated the plasma lipidome.
• Pathway analyses revealed age-related metabolic processes in healthy foals, while inflammation-related pathways were prominent in subclinical infections.
Inflammatory Mediators:
• In subclinical foals, pathways involving alpha-linolenic and arachidonic acid metabolism were more active, potentially supporting self-resolution of infection.
• Clinical foals lacked such robust responses, highlighting the need for early identification and intervention.

67
Q

Plasma metabolome of healthy and Rhodococcus equi-infected foals over time

A

Metabolomic Changes Due to Age:
• Healthy foals showed significant decreases in metabolites such as myo-inositol, threonic acid, citric acid, amino acids, and fatty acids over the first eight weeks of life.
• These changes align with developmental processes, including shifts from colostrum to milk and increased grazing.

Metabolomic profiles differed significantly between subclinical and clinical foals:
• Subclinical Foals: Demonstrated metabolic shifts that likely support recovery and inflammation resolution. Key metabolites such as linoleic acid and tryptophan increased, indicating effective immune responses.
• Clinical Foals: Showed fewer age-related metabolic changes and lacked increases in metabolites associated with inflammation resolution, suggesting a less effective response to infection.

Pathway Analysis:
• Healthy Foals: Metabolic pathways involved amino acid metabolism, carbohydrate metabolism, and lipid metabolism.
• Subclinical Foals: Displayed additional pathways linked to antioxidant and inflammatory responses, indicating adaptive processes to resolve infection.
• Clinical Foals: Pathways were predominantly linked to oxidative stress and energy metabolism, reflecting the physiological burden of severe infection.

Inflammatory Responses:
• Subclinical foals exhibited active pathways for inflammation resolution, such as linoleic acid metabolism, which were notably absent in clinical foals. This difference underscores the potential for metabolic markers to predict the severity of infection.
Antioxidant Mechanisms:
• Increased levels of metabolites like aconitic acid and tryptophan in subclinical foals highlight their roles in combating oxidative stress and supporting immune function.
• Clinical foals lacked robust antioxidant responses, which could explain their poor outcomes.

68
Q

Synergistic combinations of clarithromycin with doxycycline or minocycline reduce antimicrobial resistance

A

In vitro study, limited strains

• combinations of clarithromycin with doxycycline or minocycline, but not with rifampin, were generally synergistic in both sensitive and resistant strains
• all antibiotics, both alone and in combination, reduced viable ClaS /RifS R equi by more than 3 log10 at 24 hours compared with control cultures without antibiotics.
• Doxycycline, minocycline and combinations of clarithromycin with doxycycline or minocycline reduced viable R equi in resistant isolates, similar to those in sensitive isolates. Clarithromycin, rifampin or their combinations did not
• in resistant strains- the addition of clarithromycin to doxy/mino had only a mild effect (2-4x MPC)
• clarithromycin/rifampin combination did not markedly decrease MPCs of the individual antimicrobials in ClaR/RifR R equi isolates,
•doxycycline and minocycline were largely equivalent

Clarithromycin with Doxycycline or Minocycline:
• Demonstrated consistent synergy in checkerboard assays for both clarithromycin-susceptible and -resistant strains.
Clarithromycin with Rifampin:
• Although commonly used in clinical settings, this combination showed limited synergy or indifference in the study.
Time-Kill Assay Results:
• Clarithromycin in combination with doxycycline or minocycline significantly reduced bacterial growth in both susceptible and resistant strains.
• However, these combinations were not markedly superior in time-kill assays compared to the individual antibiotics.

Limitations of Rifampin:
• Previous studies supported the synergy of clarithromycin-rifampin combinations. However, the authors attribute discrepancies in synergy findings to differences in experimental conditions (e.g., media composition and isolate characteristics).
• Rifampin is linked to reduced plasma concentrations of macrolides, potentially undermining therapeutic effectiveness.
Tetracyclines as Alternatives:
• Both doxycycline and minocycline offer cost-effective and safer alternatives to macrolides, with proven efficacy against resistant R. equi strains.
• Clinical trials have demonstrated the comparable efficacy of doxycycline-based combinations with traditional macrolide-rifampin treatments.

Implications for Resistance Management:
•The study reinforces the role of combination therapy in restricting resistance by targeting diverse bacterial mechanisms.
• Maintaining drug concentrations within the MSW is crucial to preventing resistant mutant selection. The observed MPC reductions for clarithromycin and tetracycline combinations strongly support this approach.

69
Q

Changing policy to treat foals with Rhodococcus equi pneumonia in the later course of disease decreases antimicrobial usage without increasing mortality rate

A

• In the period from 2008 to 2011, every foal with pulmonary abscesses was treated. The treatment protocol was changed in 2012 when only foals with larger lesions were treated.

Reduced Antimicrobial Usage:
• The proportion of foals treated for pneumonia dropped significantly from 81.9% (2008–2011) to 50.9% (2012–2016).
• The revised protocol allowed spontaneous recovery for foals with small or mild lesions, reducing the overall need for antibiotics.
Unchanged Mortality Rates:
• Mortality from pneumonia or R. equi infection remained low and statistically unchanged between the two periods (0.4% in 2008–2011 vs. 0.6% in 2012–2016).
• This indicates that delaying treatment did not compromise the survival of affected foals.
Improved Treatment Outcomes:
• Failure rates of the first treatment decreased significantly from 20.3% to 5.9%.
• Recurrence rates also dropped from 20.6% to 11.6% under the revised protocol.
Higher Threshold for Treatment:
• The minimum abscess score for initiating treatment increased progressively (e.g., 8 cm in 2012 to 15 cm in 2016), reflecting more stringent criteria for treatment. The abscess score at the beginning of treatment increased from a median of 4-11.5 cm. The median number of pulmonary lesions >1 cm at onset of therapy also increased significantly from 2 compared with 7. The age at which treatment started also significantly increased.
Subclinical Monitoring:
• Foals with subclinical lesions (detected via ultrasonography) were closely monitored but not immediately treated, demonstrating the feasibility of a watchful waiting approach for mild cases.

• Independent of year and treatment group (2008-2011 vs 2012-2016) all foals with mild to moderate pneumonia were treated with the combination of rifampin/tulathromycin and foals with more severe pneumonia were treated with rifampin/azithromycin.
• Of the foals that were treated, the percentage receiving tulathromycin as part of their initial treatment regimen decreased from 71.8% (2008-2011) to 53.6%
• In the multivariable analyses, only drug treatment regimen was significantly associated with foal mortality due to R equi. Time period was not retained.
• Lower OR (0.12) and HR (0.12) for foals treated with tulathronycin vs azithromycin (milder cases)

Rational Antibiotic Use:
• The study supports targeted antibiotic therapy, which reduces the emergence of antimicrobial resistance—a growing concern for R. equi infections.
• By limiting antibiotic use to cases with larger lesions, unnecessary exposure and potential resistance development are minimized.
Ultrasound as a Diagnostic Tool:
• Ultrasonography played a crucial role in identifying lesions and guiding treatment decisions, highlighting its importance in managing endemic R. equi infections on breeding farms.
Macrolide-Rifampin Combination:
• The study reaffirmed the use of macrolides (e.g., azithromycin, tulathromycin) with rifampin as the standard treatment for more severe cases, despite concerns about resistance.

70
Q

Association between antimicrobial treatment of subclinical pneumonia in foals and selection of macrolide- and rifampicin-resistant Rhodococcus equi strains

A

Higher MRRE Soil Concentrations on TUS Farms:
• Soil concentrations of MRRE were significantly higher on farms that used TUS and prophylactic antimicrobial treatment (TUS farms) compared to those that did not (non-TUS farms).
• The mean MRRE concentration for TUS farms was 8.85 log10 CFUs/g, compared to 7.37 log10 CFUs/g for non-TUS farms.
Temporal Patterns in MRRE Prevalence:
• On non-TUS farms, MRRE concentrations varied seasonally, peaking in March and May and declining by July.
• TUS farms showed consistent MRRE concentrations across the sampling months, suggesting ongoing selective pressure due to antimicrobial use.
Antimicrobial Practices:
• TUS farms treated a higher percentage of foals with macrolides, alone or in combination with rifampin (median of 9% treated foals), compared to non-TUS farms (median of 4%).
• The incomplete intestinal absorption and fecal excretion of macrolides likely contributed to the elevated MRRE concentrations in soil.

71
Q

Opsonization but not pretreatment of equine macrophages with hyperimmune plasma nonspecifically enhances phagocytosis and intracellular killing of Rhodococcus equi

A

Study uses mares’ adult macrophages in vitro

Pretreatment of AMs
• No Enhancement: Pretreatment of AMs with HIP or NP did not enhance phagocytosis or intracellular killing.
• Reduced Phagocytosis: Both HIP and NP modestly but significantly decreased phagocytosis compared to untreated controls.
• Replication Ratios Unchanged: Pretreatment had no impact on intracellular replication ratios of R. equi.
Effects of Opsonization:
• Increased Phagocytosis: Opsonization of R. equi with HIP or NP significantly increased phagocytosis by AMs compared to non-opsonized bacteria. No difference in phagocytosis enhancement between HIP and NP.
• Reduced Intracellular Survival: Both HIP and NP significantly reduced intracellular replication of R. equi compared to non-opsonized controls. No significant difference between HIP and NP in reducing bacterial replication.

Mechanisms of Action:
• Antibody-Mediated Effects: Enhanced phagocytosis likely mediated by Fc receptor interactions through antibody-opsonized bacteria.
• Presence of anti-R. equi antibodies in NP may explain its similar efficacy to HIP in enhancing macrophage functions.
• Clinical benefits of HIP likely derive from mechanisms beyond macrophage activation.

72
Q

Randomized controlled trial comparing Rhodococcus equi and poly‐N‐acetyl glucosamine hyperimmune plasma to prevent R equi pneumonia in foals

A

• The study compares Rhodococcus equi hyperimmune plasma (RE HIP) and β-1→6-poly-N-acetyl glucosamine hyperimmune plasma (PNAG HIP) in preventing R. equi pneumonia in foals.
• Conducted as a randomized, controlled, and blinded clinical trial across five large breeding farms in the United States.
• The study aimed to determine whether PNAG HIP provided superior protection against pneumonia compared to RE HIP.

Efficacy of RE HIP vs. PNAG HIP:
• No significant difference in the incidence of pneumonia between foals transfused with RE HIP (14%) and PNAG HIP (14%).
• Odds of developing pneumonia were not significantly different between the two plasma types after adjusting for farm effects (Odds Ratio [OR]: 0.74; 95% CI: 0.44–1.23, P = 0.24).
Farm-Specific Variations:
• Pneumonia rates varied significantly between farms.
• At some farms, PNAG HIP was more effective, while at others, RE HIP had a slight advantage.
• Incidence of pneumonia was six times higher at one farm (New York) compared to the reference farm (Texas 1), emphasizing the importance of local environmental and management factors.

• Three foals (0.7%) died from pneumonia, all of whom received RE HIP. This result was not statistically significant due to the small number of deaths.
• Findings suggest no clear superiority of PNAG HIP over RE HIP in preventing R. equi pneumonia under field conditions.
• Both plasma types may provide similar levels of protection, depending on environmental and farm-specific factors.
• breeding farm management appears to be more crucial than selection of plasma

73
Q

Association of pneumonia with concentrations of virulent Rhodococcus equi in fecal swabs of foals before and after intrabronchial infection with virulent R. equi

A

Investigates the association between fecal concentrations of virulent Rhodococcus equi (R. equi) and the risk of pneumonia in foals.
Examines the impact of intragastric gavage with live, virulent R. equi (LVRE) on subsequent immune responses and pneumonia development.
Suggests the role of the gut-lung axis in immunity to R. equi and implications for disease prevention.

Association Between Fecal Concentrations and Pneumonia:
• Higher fecal concentrations of virulent R. equi (vapA copies) at 28 days were associated with reduced pneumonia risk.
• Pneumonic foals had significantly lower fecal vapA concentrations (mean: 25 copies/100 ng DNA) before intrabronchial (IB) infection compared to healthy control foals (mean: 280 copies/100 ng DNA) and gavaged foals (mean: 707 copies/100 ng DNA).
Impact of Intragastric Gavage with LVRE:
• Gavage with LVRE protected all treated foals from developing pneumonia.
• Gavaged foals had high fecal vapA concentrations before IB infection but showed a marked decrease (mean: 4 copies/100 ng DNA) after IB infection, indicating potential clearance of R. equi.
Post-Infection Fecal Concentrations:
• Pneumonic foals exhibited a significant post-infection increase in fecal vapA concentrations (mean: 9401 copies/100 ng DNA), likely from swallowing inhaled or expectorated R. equi.
• Healthy control foals showed a smaller, non-significant increase (mean: 4116 copies/100 ng DNA).
Seasonal and Environmental Effects:
• Fecal vapA concentrations were higher in foals born in April or May compared to earlier months.
• Seasonal variations in environmental R. equi concentrations or warmer temperatures may have contributed to this difference.

• Natural ingestion of virulent R. equi may contribute to immunity and reduced pneumonia risk. Coprophagia and ingestion of soil or airborne R. equi may act as natural immunizing mechanisms.
• Gavage with LVRE appears to reduce the risk of pneumonia and intestinal colonization by virulent R. equi.
• Suggests a broader approach to managing R. equi infection, focusing on both intestinal and pulmonary exposures.

74
Q

Fecal concentration of Rhodococcus equi determined by quantitative polymerase chain reaction of rectal swab samples to differentiate foals with pneumonia from healthy foals

A

• This study assesses the diagnostic accuracy of quantitative PCR (qPCR) for detecting virulent Rhodococcus equi (vapA) in fecal samples collected via rectal swabs from foals with pneumonia compared to healthy controls.
• Highlights the challenges of developing noninvasive diagnostic methods to guide more judicious antimicrobial use.

Diagnostic Accuracy:
• Fecal concentrations of virulent R. equi (vapA copies) were significantly higher in pneumonic foals compared to healthy controls.
• Area under the Receiver Operating Characteristic (ROC) curve was 83.7%, indicating moderate diagnostic accuracy.
• At an optimal threshold of 14,883 vapA copies/100 ng DNA:
-Sensitivity: 79.5%.
-Specificity: 83.0%
• Concentrations of vapA in feces differed significantly between farms for pneumonic foals but not for healthy controls.
• Highlights the need to account for farm-specific factors in diagnostic evaluations.

Control Foals Developing Pneumonia:
• Eight foals initially classified as healthy controls later developed pneumonia.
• Median fecal vapA concentrations increased significantly from 14,330 to 216,948 copies/100 ng DNA, underscoring the dynamic nature of infection.

• Diagnostic performance likely overestimated due to the case-control design, which tends to overemphasize differences between cases and controls.

• Rectal swab sampling offers a practical, minimally invasive alternative for assessing virulent R. equi.
• Despite moderate accuracy, qPCR-based testing needs refinement before clinical adoption.

75
Q

Efficacy of the combination of doxycycline and azithromycin for the treatment of foals with mild to moderate bronchopneumonia

A

• This study evaluates the efficacy of a combination of azithromycin (AZM) and doxycycline (DOX) compared to azithromycin and rifampin (AZM-RIF) for treating mild to moderate bronchopneumonia in foals.
• Conducted as a randomized, controlled, double-blinded trial at a farm endemic for Rhodococcus equi infections.
• The study emphasizes the importance of alternative treatments due to increasing scrutiny over the veterinary use of rifampin (RIF).

Efficacy of AZM-DOX:
•AZM-DOX was noninferior to AZM-RIF for treating foals with lesion scores between 10–15 cm.
• Recovery rates:
-AZM-DOX: 98.7% (80/81 foals).
-AZM-RIF: 100% (81/81 foals).
-Control (no treatment): 73.1% (57/78 foals).
• Risk of treatment failure was significantly lower in both AZM-DOX and AZM-RIF groups compared to controls.

Safety Profile:
• Mild increases in serum creatinine and blood urea nitrogen (BUN) were observed in both AZM-DOX and AZM-RIF groups, but values remained within normal limits.
• Diarrhea incidence was lower in foals treated with AZM-DOX (13.6%) compared to AZM-RIF (32.1%) and controls (25.6%).
• Diarrhea was generally mild and self-limiting, requiring therapy in only two foals.
• AZM-DOX had a lower incidence rate ratio for diarrhea compared to both AZM-RIF and controls.

• For foals with advanced pulmonary lesions or severe respiratory disease, AZM-RIF remains the treatment of choice.

76
Q

Comparison of the efficacy of rifampin/azithromycin and rifampin/tulathromycin for the treatment of foals affected with pneumonia

A

• This study compares the efficacy of rifampin/azithromycin (R/A) and rifampin/tulathromycin (R/T) combinations for treating moderate to severe pneumonia in foals. (‘abscessing pneumonia’ definitive dx not obtained)
• It evaluates the speed of pulmonary abscess resolution and long-term treatment success across two antimicrobial protocols.

Recovery rates were comparable:
• R/A: 91.7% (67/73 foals).
• R/T: 89.6% (78/87 foals).
• Both groups showed a 50% reduction in abscess score within the first two weeks, demonstrating similar effectiveness.
• Most foals required three weeks of treatment to recover fully:
-R/A: 64.4% recovered within three weeks.
-R/T: 59.7% recovered within three weeks.
• Average treatment duration:
-R/A: 22.7 ± 9.5 days.
-R/T: 21.8 ± 8 days.
• Recurrence and Long-Term Outcomes:
- Recurrence rates were low, with only 4 foals (2.5%) developing new pneumonia four weeks post-treatment.
- Both combinations ensured good long-term outcomes when treatment was closely monitored.

Advantages of R/T Combination:
• R/T required fewer administrations (once-weekly tulathromycin injections) compared to daily oral azithromycin, making it less labor-intensive and potentially more cost-effective.
Choice of Treatment:
• Both R/A and R/T are effective for treating moderate to severe bronchopneumonia in foals.
• Selection between R/A and R/T should consider labor, cost, and risk of antimicrobial resistance.